
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            In Silico identification and modelling of FDA-approved drugs targeting T-type calcium channels - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="4DDE49D689B776F31B49D60002E4090A.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334052/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS One">
<meta name="citation_title" content="In Silico identification and modelling of FDA-approved drugs targeting T-type calcium channels">
<meta name="citation_author" content="Pedro Fong">
<meta name="citation_author_institution" content="Faculty of Health Sciences and Sports, Macao Polytechnic University, Macao SAR, China">
<meta name="citation_author_institution" content="School of Informatics, University of Edinburgh, Edinburgh, United Kingdom">
<meta name="citation_author" content="Susana Roman Garcia">
<meta name="citation_author_institution" content="Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom">
<meta name="citation_author" content="Melanie I Stefan">
<meta name="citation_author_institution" content="Faculty of Medicine, Medical School Berlin, Berlin, Germany">
<meta name="citation_author" content="David C Sterratt">
<meta name="citation_author_institution" content="School of Informatics, University of Edinburgh, Edinburgh, United Kingdom">
<meta name="citation_publication_date" content="2025 Aug 8">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0327386">
<meta name="citation_doi" content="10.1371/journal.pone.0327386">
<meta name="citation_pmid" content="40779495">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334052/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334052/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334052/pdf/pone.0327386.pdf">
<meta name="description" content="Studies have shown that inhibition of the Cav3.1 T-type calcium channel can prevent or suppress neurological diseases, such as epileptic seizures and diabetic neuropathy. In this study, we aimed to use in silico simulations to identify a U.S. Food ...">
<meta name="og:title" content="In Silico identification and modelling of FDA-approved drugs targeting T-type calcium channels">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Studies have shown that inhibition of the Cav3.1 T-type calcium channel can prevent or suppress neurological diseases, such as epileptic seizures and diabetic neuropathy. In this study, we aimed to use in silico simulations to identify a U.S. Food ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334052/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12334052">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0327386"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0327386.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334052%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12334052/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12334052/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334052/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0327386" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2025 Aug 8;20(8):e0327386. doi: <a href="https://doi.org/10.1371/journal.pone.0327386" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0327386</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>
<em>In Silico</em> identification and modelling of FDA-approved drugs targeting T-type calcium channels</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fong%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Pedro Fong</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Pedro Fong</span></h3>
<div class="p">
<sup>1</sup>Faculty of Health Sciences and Sports, Macao Polytechnic University, Macao SAR, China</div>
<div class="p">
<sup>2</sup>School of Informatics, University of Edinburgh, Edinburgh, United Kingdom</div>
<div>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fong%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Pedro Fong</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Garcia%20SR%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Susana Roman Garcia</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Susana Roman Garcia</span></h3>
<div class="p">
<sup>3</sup>Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom</div>
<div>Project administration, Supervision, Validation, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Garcia%20SR%22%5BAuthor%5D" class="usa-link"><span class="name western">Susana Roman Garcia</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stefan%20MI%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Melanie I Stefan</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Melanie I Stefan</span></h3>
<div class="p">
<sup>4</sup>Faculty of Medicine, Medical School Berlin, Berlin, Germany</div>
<div>Formal analysis, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stefan%20MI%22%5BAuthor%5D" class="usa-link"><span class="name western">Melanie I Stefan</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sterratt%20DC%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">David C Sterratt</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">David C Sterratt</span></h3>
<div class="p">
<sup>2</sup>School of Informatics, University of Edinburgh, Edinburgh, United Kingdom</div>
<div>Formal analysis, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sterratt%20DC%22%5BAuthor%5D" class="usa-link"><span class="name western">David C Sterratt</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">Rajesh Kumar Pathak</span><sup>5</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Faculty of Health Sciences and Sports, Macao Polytechnic University, Macao SAR, China</div>
<div id="aff002">
<sup>2</sup>School of Informatics, University of Edinburgh, Edinburgh, United Kingdom</div>
<div id="aff003">
<sup>3</sup>Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom</div>
<div id="aff004">
<sup>4</sup>Faculty of Medicine, Medical School Berlin, Berlin, Germany</div>
<div id="edit1">
<sup>5</sup>Chung-Ang University, KOREA, REPUBLIC OF</div>
<div class="author-notes p">
<div class="fn" id="cor001">
<sup><em>*</em></sup><p class="display-inline">
<span>pedrofong@mpu.edu.mo</span> (PF); <span>david.c.sterratt@ed.ac.uk</span> (DS)</p>
</div>
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Pedro Fong</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft</span>
</div>
<div>
<strong class="contrib"><span class="name western">Susana Roman Garcia</span></strong>: <span class="role">Project administration, Supervision, Validation, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Melanie I Stefan</span></strong>: <span class="role">Formal analysis, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">David C Sterratt</span></strong>: <span class="role">Formal analysis, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Rajesh Kumar Pathak</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Dec 29; Accepted 2025 Jun 15; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Fong et al</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12334052  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40779495/" class="usa-link">40779495</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Studies have shown that inhibition of the Ca<sub>v</sub>3.1 T-type calcium channel can prevent or suppress neurological diseases, such as epileptic seizures and diabetic neuropathy. In this study, we aimed to use <em>in silico</em> simulations to identify a U.S. Food and Drug Administration (FDA)-approved drug that can bind to the Ca<sub>v</sub>3.1 T-type calcium channel. We used the automated docking suite GOLD v5.5 with the genetic algorithm to simulate molecular docking and predict the protein-ligand binding modes, and the ChemPLP empirical scoring function to estimate the binding affinities of 2,115 FDA-approved drugs to the human Ca<sub>v</sub>3.1 channel. Drugs with high binding affinity and appropriate pharmacodynamic and pharmacokinetic properties were selected for molecular mechanics Poisson–Boltzmann surface area (MMPBSA) and molecular mechanics generalised Born surface area (MMGBSA) binding free energy calculations, GROMACS molecular dynamics (MD) simulations and Monte Carlo Cell (MCell) simulations. The docking results indicated that the FDA-approved drug montelukast has a high binding affinity to Ca<sub>v</sub>3.1, and data from the literature suggested that montelukast has the appropriate drug-like properties to cross the human blood-brain barrier and reach synapses in the central nervous system. MMPBSA, MMGBSA, and MD simulations showed the high stability of the montelukast-Ca<sub>v</sub>3.1 complex. MCell simulations indicated that the blockage of Ca<sub>v</sub>3.1 by montelukast reduced the number of synaptic vesicles being released from the pre-synaptic region to the synaptic cleft, which may reduce the probability and amplitude of postsynaptic potentials.</p></section><section id="sec001"><h2 class="pmc_sec_title">Introduction</h2>
<p>Calcium channels are located in the plasma membrane of excitable cells, including neurons, brain cells and heart muscle cells [<a href="#pone.0327386.ref001" class="usa-link" aria-describedby="pone.0327386.ref001">1</a>]. These channels allow the influx of calcium ions into the cells and cause depolarisation and excitation, contributing to the biological functions of the cells [<a href="#pone.0327386.ref001" class="usa-link" aria-describedby="pone.0327386.ref001">1</a>]. Blocking the influx of calcium ions has been shown to have pharmacological effects. For example, ziconotide is a calcium channel blocker medication that inhibits the influx of calcium ions into neurons, consequently reducing neurotransmitter release and dampening neuronal excitability. This reduction in excitability leads to its analgesic effects and makes ziconotide a treatment for severe chronic pain [<a href="#pone.0327386.ref002" class="usa-link" aria-describedby="pone.0327386.ref002">2</a>,<a href="#pone.0327386.ref003" class="usa-link" aria-describedby="pone.0327386.ref003">3</a>].</p>
<p>Calcium channels can be categorised into voltage-gated and ligand-gated; the opening and closing of the former respond to a voltage difference, while the latter is governed by ligand binding. Voltage-gated calcium channels are subcategorised according to their response to voltage and temporal dynamics into L-type (long-lasting), N-type (neural), P-type (Purkinje), R-type (residual) and T-type (transient) [<a href="#pone.0327386.ref004" class="usa-link" aria-describedby="pone.0327386.ref004">4</a>]. Their distribution throughout the human body varies by type; for example, N-type channels are typically found in the brain, R-type channels in neurons, and L-type channels in muscles, bones, myocytes and dendrites. This study aims to find an inhibitor of the T-type channel, which is widely distributed across the central nervous system [<a href="#pone.0327386.ref004" class="usa-link" aria-describedby="pone.0327386.ref004">4</a>].</p>
<p>T-type calcium channels have three subcategories: Ca<sub>v</sub>3.1, Ca<sub>v</sub>3.2 and Ca<sub>v</sub>3.3, which are all associated with neurological diseases, such as epilepsy, neuralgia, diabetic neuropathy, nerve injury and sleep disorders [<a href="#pone.0327386.ref005" class="usa-link" aria-describedby="pone.0327386.ref005">5</a>]. Ca<sub>v</sub>3.1 is primarily expressed in the central nervous system and is involved in the generation of rhythmic activities such as sleep patterns and regulating neuronal firing patterns, and its over-activation may cause neurons to fire at an abnormally high frequency, leading to epileptic seizures [<a href="#pone.0327386.ref005" class="usa-link" aria-describedby="pone.0327386.ref005">5</a>]. A prior study provoked seizures in wild-type mice lacking Ca<sub>v</sub>3.1 through intraperitoneal drug administration, revealing that the Ca<sub>v</sub>3.1 knockout mice have significantly less risk of absence seizures [<a href="#pone.0327386.ref004" class="usa-link" aria-describedby="pone.0327386.ref004">4</a>]. Ca<sub>v</sub>3.2 contributes to various physiological processes such as hormone secretion, neurotransmitter release, and regulation of cardiac pacemaker activity [<a href="#pone.0327386.ref006" class="usa-link" aria-describedby="pone.0327386.ref006">6</a>]. It is also associated with epilepsy, but its activation may not be strong enough to produce seizures [<a href="#pone.0327386.ref006" class="usa-link" aria-describedby="pone.0327386.ref006">6</a>]. Ca<sub>v</sub>3.3 channels are mainly found in the thalamus and play a crucial role in generating and modulating neuronal oscillations, sensory processing, and serving as the primary pacemaker for sleep spindles [<a href="#pone.0327386.ref007" class="usa-link" aria-describedby="pone.0327386.ref007">7</a>]. Thus, all three types of calcium channels are considered potential drug targets for neurological diseases [<a href="#pone.0327386.ref001" class="usa-link" aria-describedby="pone.0327386.ref001">1</a>]. Ca<sub>v</sub>3.1 is the most studied and is most associated with epileptic seizures. The objective of this study is to identify a U.S. Food and Drug Administration (FDA)-approved drug that can bind to the Ca<sub>v</sub>3.1 T-type calcium channels using <em>in silico</em> simulations.</p>
<p>The first stage of most drug discovery projects is <em>in silico</em> simulations [<a href="#pone.0327386.ref008" class="usa-link" aria-describedby="pone.0327386.ref008">8</a>], which help to identify potential drug candidates for further experiments. In general, the process starts with the creation of a library containing a large number of molecules. This library can be obtained from a chemical compound database, such as the ZINC database [<a href="#pone.0327386.ref009" class="usa-link" aria-describedby="pone.0327386.ref009">9</a>]. ZINC classifies compounds into different categories; for example, herbal ingredients, human metabolites and FDA-approved drugs. After the selection and compilation of a compound library, screening is performed to identify potential molecules that can bind to the selected therapeutic target. The drug-like properties, such as adsorption, distribution, metabolism, excretion and toxicity, of these compounds are then predicted using various <em>in silico</em> methods [<a href="#pone.0327386.ref010" class="usa-link" aria-describedby="pone.0327386.ref010">10</a>]. If required, the structures of these molecules can be modified to bind more tightly to the target or to have advanced drug-like properties, such as fewer side effects and higher bioavailability.</p>
<p>The <em>in silico</em> methods used in this study were molecular docking, molecular mechanics Poisson–Boltzmann/generalised Born surface area (MMPBSA/MMGBSA), molecular dynamics (MD) and Monte Carlo (MCell) simulations. The docking simulations were employed to identify an FDA-approved drug that has a high potential to bind with Ca<sub>v</sub>3.1. The MMPBSA/MMGBSA and MD simulations were used to validate that the identified FDA-approved drug can bind to Ca<sub>v</sub>3.1 with high stability. A pre-synaptic MCell model was created to simulate the effect of the chosen FDA-approved drug on lowering neurotransmitter release and weakening the neural signal by competing with calcium ions for the Ca<sub>v</sub>3.1 channels.</p>
<p>Using these methods, we identified montelukast as a promising candidate to bind Ca<sub>v</sub>3.1 channels and reduce the hyperactivity of presynaptic neurons. Further experimental studies are necessary to establish the feasibility of repurposing montelukast for the treatment of epilepsy and related conditions.</p></section><section id="sec002"><h2 class="pmc_sec_title">Results and discussion</h2>
<section id="sec003"><h3 class="pmc_sec_title">Molecular docking</h3>
<p>Docking simulations were performed between the selected ligand-bound Ca<sub>v</sub>3.1 structure (<a href="#pone.0327386.g001" class="usa-link">Fig 1</a>, PDB code 6KZP) and 2,115 FDA-approved drugs. The results show that 234 drugs obtained a higher binding score than the native ligand embedded in the crystal structure of the Ca<sub>v</sub>3.1 (PDB: Z944), indicating that these compounds may inhibit the opening of the calcium channel and block the entry of calcium ions into the neurons. The FDA-approved drugs with the top 20 binding scores are shown in <a href="#pone.0327386.t001" class="usa-link">Table 1</a> [<a href="#pone.0327386.ref011" class="usa-link" aria-describedby="pone.0327386.ref011">11</a>]. Indocyanine green obtained the highest score. Its 2D chemical structure is larger than the Z944 structure and contains more flexible single bonds, which are located near the two highly polar bisulphite groups (<a href="#pone.0327386.g002" class="usa-link">Fig 2</a>). These features may enable the indocyanine green to fit more naturally in the binding site of Ca<sub>v</sub>3.1. The second (cobicistat) and third (ritonavir) ranked drugs also have larger and more flexible structures than the native ligand (<a href="#pone.0327386.g002" class="usa-link">Fig 2</a>).</p>
<figure class="fig xbox font-sm" id="pone.0327386.g001"><h4 class="obj_head">Fig 1. Surface and cartoon view of the native ligand (Z944) in the human Ca<sub>v</sub>3.1 (PDB: 6KZP).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46e/12334052/047d16f57d69/pone.0327386.g001.jpg" loading="lazy" height="870" width="800" alt="Fig 1"></p>
<div class="p text-right font-secondary"><a href="figure/pone.0327386.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The binding site is indicated by the red dotted line.</p></figcaption></figure><section class="tw xbox font-sm" id="pone.0327386.t001"><h4 class="obj_head">Table 1. Clinical uses of the top 20 docking-scored FDA-approved drugs.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Drug name</th>
<th align="left" rowspan="1" colspan="1">Score</th>
<th align="left" rowspan="1" colspan="1">Clinical use [<a href="#pone.0327386.ref011" class="usa-link" aria-describedby="pone.0327386.ref011">11</a>]</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Native (Z944)</td>
<td align="left" rowspan="1" colspan="1">62.90</td>
<td align="left" rowspan="1" colspan="1">No clinical usage can be found</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Indocyanine green</td>
<td align="left" rowspan="1" colspan="1">110.68</td>
<td align="left" rowspan="1" colspan="1">Diagnostic agent uses in angiography</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cobicistat</td>
<td align="left" rowspan="1" colspan="1">110.63</td>
<td align="left" rowspan="1" colspan="1">CYP3A inhibitor uses to increase the efficiency of antivirus</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ritonavir</td>
<td align="left" rowspan="1" colspan="1">108.20</td>
<td align="left" rowspan="1" colspan="1">HIV protease inhibitors</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Glycerol phenylbutyrate</td>
<td align="left" rowspan="1" colspan="1">107.56</td>
<td align="left" rowspan="1" colspan="1">Uses for Inborn urea cycle disorders</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Carfilzomib</td>
<td align="left" rowspan="1" colspan="1">102.35</td>
<td align="left" rowspan="1" colspan="1">Proteasome inhibitors used in multiple myeloma</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Saquinavir</td>
<td align="left" rowspan="1" colspan="1">101.96</td>
<td align="left" rowspan="1" colspan="1">HIV protease inhibitors</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dabigatran</td>
<td align="left" rowspan="1" colspan="1">101.49</td>
<td align="left" rowspan="1" colspan="1">Uses as anticoagulant</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Montelukast</td>
<td align="left" rowspan="1" colspan="1">100.71</td>
<td align="left" rowspan="1" colspan="1">Leukotriene inhibitor use for asthma</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Fosinopril</td>
<td align="left" rowspan="1" colspan="1">100.48</td>
<td align="left" rowspan="1" colspan="1">Angiotensin-converting enzyme inhibitor uses for hypertension</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dronedarone</td>
<td align="left" rowspan="1" colspan="1">100.44</td>
<td align="left" rowspan="1" colspan="1">Antiarrhythmic drug</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Azilsartan</td>
<td align="left" rowspan="1" colspan="1">99.26</td>
<td align="left" rowspan="1" colspan="1">Angiotensin II receptor antagonist uses for hypertension</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gadofosveset</td>
<td align="left" rowspan="1" colspan="1">98.86</td>
<td align="left" rowspan="1" colspan="1">Gadolinium-based MRI contrast agent</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Atorvastatin</td>
<td align="left" rowspan="1" colspan="1">98.84</td>
<td align="left" rowspan="1" colspan="1">Statin uses for hypercholesterolemia</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Naloxegol</td>
<td align="left" rowspan="1" colspan="1">97.43</td>
<td align="left" rowspan="1" colspan="1">
<em>µ</em>-opioid receptor antagonist uses for constipation</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Indinavir</td>
<td align="left" rowspan="1" colspan="1">96.74</td>
<td align="left" rowspan="1" colspan="1">HIV protease inhibitor</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Silodosin</td>
<td align="left" rowspan="1" colspan="1">96.64</td>
<td align="left" rowspan="1" colspan="1">α<sub>1</sub>-adrenoceptor antagonist uses for benign pro- static hyperplasia</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Nonoxynol-9</td>
<td align="left" rowspan="1" colspan="1">96.42</td>
<td align="left" rowspan="1" colspan="1">Vaginal spermicide</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Isavuconazonium</td>
<td align="left" rowspan="1" colspan="1">96.23</td>
<td align="left" rowspan="1" colspan="1">Triazole uses as antifungal agent</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lomitapide</td>
<td align="left" rowspan="1" colspan="1">95.40</td>
<td align="left" rowspan="1" colspan="1">Microsomal triglyceride transfer protein inhibitor uses for hypercholesterolemia.</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0327386.t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><figure class="fig xbox font-sm" id="pone.0327386.g002"><h4 class="obj_head">Fig 2. Chemical structures of (A) indocyanine green, (B) cobicistat, (C) ritonavir, (D) native ligand (PDB: 6KZP) and (E) montelukast.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334052_pone.0327386.g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46e/12334052/0893cd9510d9/pone.0327386.g002.jpg" loading="lazy" height="504" width="660" alt="Fig 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0327386.g002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>Although indocyanine green obtained the highest score, we do not believe that it is suitable for the drug repurposing aim of this study. We aimed to find a Ca<sub>v</sub>3.1 inhibitor to treat neurological disorders, such as epileptic seizures, that generally require long-term regular use. However, indocyanine green is a diagnostic agent for angiography, and no studies can be found on the safety of its long-term regular use [<a href="#pone.0327386.ref012" class="usa-link" aria-describedby="pone.0327386.ref012">12</a>]. Thus, regular administration may not be appropriate. Cobicistat obtained the second highest binding score (<a href="#pone.0327386.t001" class="usa-link">Table 1</a>); it is a CYP3A (cytochrome P450, family 3, subfamily A) inhibitor used to increase the systemic exposure and hence the effectiveness of the HIV drugs atazanavir or darunavir [<a href="#pone.0327386.ref013" class="usa-link" aria-describedby="pone.0327386.ref013">13</a>]. CYP3A is a group of enzymes involved in the metabolism of many drugs; thus, cobicistat can cause various drug-drug interactions [<a href="#pone.0327386.ref013" class="usa-link" aria-describedby="pone.0327386.ref013">13</a>], and we do not therefore believe it to be appropriate for regular use.</p>
<p>The third- and fourth-ranked drugs were ritonavir and saquinavir. They are HIV antiviral drugs, and using them regularly may significantly increase drug resistance and worsen the global problems of HIV drug effectiveness [<a href="#pone.0327386.ref014" class="usa-link" aria-describedby="pone.0327386.ref014">14</a>]. Glycerol phenylbutyrate was the fifth-ranked drug; it is an oral medication for inborn urea cycle disorders. However, it has a poor side effect profile: 16% of patients had diarrhoea, 14% had flatulence, 14% had a headache, and 7% had abdominal pain [<a href="#pone.0327386.ref015" class="usa-link" aria-describedby="pone.0327386.ref015">15</a>]. The next ranked drug is carfilzomib, which is used as a treatment for myeloma. It only has parenteral administration and can cause serious side effects [<a href="#pone.0327386.ref016" class="usa-link" aria-describedby="pone.0327386.ref016">16</a>]. Dabigatran is the next-ranked drug; it is an anticoagulant with a high risk of bleeding as a side effect [<a href="#pone.0327386.ref017" class="usa-link" aria-describedby="pone.0327386.ref017">17</a>]. Thus, all the above-mentioned drugs may not be appropriate for regular use to treat neurological disorders, such as epileptic seizures.</p>
<p>Montelukast obtained the eighth highest ranking score of 100.7 (<a href="#pone.0327386.t001" class="usa-link">Table 1</a>), which is higher than the value of 62.9 for Z944. The docking conformation analysis shows that there were 15 hydrophobic contacts between montelukast and the amino acid residues in the binding site (<a href="#pone.0327386.g003" class="usa-link">Figs 3A</a> and <a href="#pone.0327386.g003" class="usa-link">B</a>). In contrast, the native ligand had hydrophobic contact with only 10 residues (<a href="#pone.0327386.g003" class="usa-link">Figs 3C</a> and <a href="#pone.0327386.g003" class="usa-link">D</a>). Most of these residues are different for montelukast and Z944; only three, Leu 872, Leu 920 and Phe 956, possess hydrophobic contacts with both montelukast and Z944. The other contact residues for montelukast are Ile 351, Thr 352, Leu 353, Ser 383, Ile 387, Gln 922 and Tyr 953 for Z994, and Asn 388, Leu 391, Phe 917, Thr 921, Asn 952, Lys 1462, Val 1505, Leu 1506, Phe 1509, Gln 1816, Val 1820 and Val 1823.</p>
<figure class="fig xbox font-sm" id="pone.0327386.g003"><h4 class="obj_head">Fig 3. 2D and 3D illustration of the docked structures between human Ca<sub>v</sub>3.1 (PDB: 6KZP) and native ligand and montelukast, generated by Pymol and LigPlot + .</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334052_pone.0327386.g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46e/12334052/35070f679b08/pone.0327386.g003.jpg" loading="lazy" height="442" width="763" alt="Fig 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0327386.g003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The annotated yellow dotted lines indicate the distance between the atoms, measured in angstroms. The green dotted lines represent hydrogen bonding. The red spoked arcs indicate the residues making hydrophobic contacts with the ligand.</p></figcaption></figure><p>Montelukast is a leukotriene receptor antagonist that has been approved by the FDA for the treatment of asthma and allergic rhinitis since 1998 [<a href="#pone.0327386.ref018" class="usa-link" aria-describedby="pone.0327386.ref018">18</a>]. Millions of asthmatic patients around the world have been taking it regularly, generally as 10 mg once daily by mouth for the prophylaxis of asthma attacks [<a href="#pone.0327386.ref018" class="usa-link" aria-describedby="pone.0327386.ref018">18</a>]. The side effects of montelukast are minimal and can be tolerated by most patients [<a href="#pone.0327386.ref018" class="usa-link" aria-describedby="pone.0327386.ref018">18</a>]. The unique chemical structure of montelukast seems to have a low affinity to many other drug targets, and this causes very few known drug-drug interactions [<a href="#pone.0327386.ref018" class="usa-link" aria-describedby="pone.0327386.ref018">18</a>]. Another advantage of montelukast is its safety in pregnancy [<a href="#pone.0327386.ref019" class="usa-link" aria-describedby="pone.0327386.ref019">19</a>,<a href="#pone.0327386.ref020" class="usa-link" aria-describedby="pone.0327386.ref020">20</a>]. This study aims to identify a drug for neurological disorders, such as epileptic seizures, and most current anti-epileptic drugs carry the risk of congenital malformation and adverse prenatal outcomes [<a href="#pone.0327386.ref021" class="usa-link" aria-describedby="pone.0327386.ref021">21</a>]. Many studies have proven that montelukast does not increase the rate of congenital malformation and can be safely used during pregnancy [<a href="#pone.0327386.ref019" class="usa-link" aria-describedby="pone.0327386.ref019">19</a>,<a href="#pone.0327386.ref020" class="usa-link" aria-describedby="pone.0327386.ref020">20</a>].</p>
<p>In addition, montelukast is known to have the ability to cross the blood-brain barrier and could produce neuroprotective effects [<a href="#pone.0327386.ref022" class="usa-link" aria-describedby="pone.0327386.ref022">22</a>,<a href="#pone.0327386.ref023" class="usa-link" aria-describedby="pone.0327386.ref023">23</a>]. An animal study showed that montelukast increased the number of neurons by 15% in mice with cranial irradiation [<a href="#pone.0327386.ref022" class="usa-link" aria-describedby="pone.0327386.ref022">22</a>]. In mice and rats, montelukast has been found to reduce neuron loss after a chronic brain injury caused by cerebral ischaemia [<a href="#pone.0327386.ref023" class="usa-link" aria-describedby="pone.0327386.ref023">23</a>]. Montelukast has also been found to inhibit the GPR17 receptor, which serves as a sensor for local damage to the myelin sheath and plays a role in the repair and regeneration of demyelinating plaques resulting from ongoing inflammation [<a href="#pone.0327386.ref024" class="usa-link" aria-describedby="pone.0327386.ref024">24</a>]. Inhibiting the GPR17 receptor in rats with Montelukast may reduce neuroinflammation, suggesting its potential use in the treatment of dementia [<a href="#pone.0327386.ref024" class="usa-link" aria-describedby="pone.0327386.ref024">24</a>].</p>
<p>Despite the beneficial effects of montelukast, studies analysed from electronic health record databases globally have found that potential neuropsychiatric adverse effects may be associated with its use, including dementia, sleep disorders, and depression [<a href="#pone.0327386.ref025" class="usa-link" aria-describedby="pone.0327386.ref025">25</a>,<a href="#pone.0327386.ref026" class="usa-link" aria-describedby="pone.0327386.ref026">26</a>]. However, a meta-analysis of 59 studies found no association between montelukast and suicide or depression, although the elderly may be more prone to sleep disorders caused by montelukast [<a href="#pone.0327386.ref027" class="usa-link" aria-describedby="pone.0327386.ref027">27</a>].</p>
<p>Another recently published review article suggested the neuroprotective property of montelukast and its potential use as an anti-epileptic drug, as it reduced the incidence and severity of seizures in epidemiological studies [<a href="#pone.0327386.ref028" class="usa-link" aria-describedby="pone.0327386.ref028">28</a>]. However, the pharmacological mechanism of these properties is not known. Our docking results show that montelukast may have a high binding affinity to Ca<sub>v</sub>3.1, which could be the reason for its neurological effects. Because of all the above-mentioned characteristics of montelukast, we selected it for further simulations to investigate its binding with Ca<sub>v</sub>3.1.</p></section><section id="sec004"><h3 class="pmc_sec_title">Molecular dynamics (MD)</h3>
<p>MD simulations were conducted on both the crystal structure of the native ligand (Z944) and the best-docked conformation of montelukast with Ca<sub>v</sub>3.1 to investigate their dynamic interactions. For the montelukast complex, three separate 100 ns MD simulations were performed to ensure more reliable results. Their root mean square deviations (RMSD), root mean square fluctuation (RMSF), radius of gyration (Rg), solvent accessible surface area (SASA), number of hydrogen bonds and interaction energies were calculated.</p>
<p>The RMSD shows the stabilities of the 6KZP-native and 6KZP-montelukast complexes (<a href="#pone.0327386.g004" class="usa-link">Fig 4A</a>). The conformations of the 6KZP-native were stabilised by about 2 ns. For the montelukast complex, three separate 100 ns MD simulations were performed to ensure more reliable results. The results from the first two MD simulations were very similar, with the complex structures stabilising around 17 ns (<a href="#pone.0327386.g004" class="usa-link">Fig 4A</a>). In contrast, the third MD simulation showed stabilisation from about 17 ns to 70 ns with a different conformation compared to the first two MDs, after which it resembled the conformations of the first and second simulations. Therefore, the first two MD runs achieved the most stable conformations much earlier than the third. The 6KZP-native complex was stabilised at an RMSD of about 0.4 nm, whereas that of the 6KZP-montelukast was 0.75 nm. A small RMSD value indicates that there were small differences in the conformation between the docked and MD-stabilised structures. In general, an RMSD value of less than 1.0 nm indicates that the docking approach can predict the binding mode of protein-ligand interactions to an acceptable standard [<a href="#pone.0327386.ref029" class="usa-link" aria-describedby="pone.0327386.ref029">29</a>]. Here, both the stabilised RMSD values of 6KZP-native and 6KZP-montelukast are below 1.0 nm.</p>
<figure class="fig xbox font-sm" id="pone.0327386.g004"><h4 class="obj_head">Fig 4. (A) RMSD, (B) RMSF, and (C) Rg of the 6KZP-native complex (in orange) and the 6KZP-montelukast complex (in blue, grey, and orange).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334052_pone.0327386.g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46e/12334052/e06d8c60c367/pone.0327386.g004.jpg" loading="lazy" height="1209" width="727" alt="Fig 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0327386.g004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Three 100 ns MD simulations were conducted on the 6KZP-montelukast complex, with labels 1, 2, and 3 indicating the 1<sup>st</sup>, 2<sup>nd</sup>, and 3<sup>rd</sup> simulations, respectively. The black dotted lines mark the regions with differing RMSF values between the 6KZP-native and 6KZP-montelukast complexes.</p></figcaption></figure><p>The RMSF results show the fluctuation behaviour of individual residues of the protein (<a href="#pone.0327386.g004" class="usa-link">Fig 4B</a>). 6KZP has about 1,200 amino acid residues. The RMSF plots of 6KZP-native and 6KZP-montelukast were similar, indicating that the conformations of both structures have a similar overall variation in stability. The 6KZP-montelukast complex has higher RMSF values than the 6KZP-native complex at residue 85 (Gln 172), 116 (Leu 205), 174 (Asn 263), 593–598 (Ser 1334 to Leu 1339), 934–935 (Glu 1749 to Thr 1750) and 978 (Asn 1800). These higher RMSF values indicate that these residues are important for the interactions between montelukast and 6KZP, but not for the native ligand. The important interaction residues for the binding between the native ligand and 6KZP are 378 (Val 823), 517 (Arg 1248), 673–691 (Cys 1418 to Ser 1436), 735–737 (Gln1480 to Pro1482), 741 (His 1486), 777 (Leu 1592) and 860 (Asn 1675).</p>
<p>Rg evaluates the compactness of the complexes (<a href="#pone.0327386.g004" class="usa-link">Fig 4C</a>). Throughout the simulation, the Rg values of the 6KZP-montelukast complex range from 3.17 nm to 3.29 nm, and those of the 6KZP-native range from 3.22 nm to 3.32 nm, suggesting that there may be a small difference in the complexes between the complexes. As shown in <a href="#pone.0327386.g004" class="usa-link">Fig 4C</a>, there is a slight increase in the 6KZP-native complex Rg curve and a slight decrease in the 6KZP-montelukast complex after 80 ns of MD simulations. The higher Rg values of the 6KZP-native complex may indicate slightly less compactness, <em>i.e.</em>, more flexible structures, than the 6KZP-montelukast complex. The protein of the montelukast complex may be folded slightly more tightly than that of the native.</p>
<p>Hydrogen bonds are one of the strongest types of bonds that are responsible for maintaining the protein structure and provide attractive interaction forces between protein and ligand. In general, hydrogen bonds are stronger than hydrophobic contacts and are considered another important facilitator for protein-ligand interactions. <a href="#pone.0327386.g005" class="usa-link">Fig 5</a> shows the number of intra- and inter-hydrogen bonds of the 6KZP-montelukast and 6KZP-native complexes. The intra-protein hydrogen bonds are those within the protein, and the intermolecular hydrogen bonds are those between the ligand and the protein. The number of intra-protein hydrogen bonds was similar for 6KZP-native and 6KZP-montelukast, mainly varying between 720 and 770 (<a href="#pone.0327386.g005" class="usa-link">Fig 5A</a>). This level of hydrogen bonds maintains the stabilised structure of the protein. Looking at the intermolecular hydrogen bonds, the 6KZP-native complex tends to have more conformations with two hydrogen bonds than the 6KZP-montelukast (<a href="#pone.0327386.g005" class="usa-link">Figs 5B</a>, <a href="#pone.0327386.g005" class="usa-link">C and D</a>). This may indicate that the higher binding affinity of 6KZP-montelukast may be caused by other intermolecular forces, such as hydrophobic contact.</p>
<figure class="fig xbox font-sm" id="pone.0327386.g005"><h4 class="obj_head">Fig 5. (A) Number of intra-hydrogen bonds for the 6KZP-native complex (orange colour) and 6KZP-montelukast complex (blue).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334052_pone.0327386.g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46e/12334052/12c4144b5789/pone.0327386.g005.jpg" loading="lazy" height="377" width="701" alt="Fig 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0327386.g005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>(B)</strong> The frequency of the number of inter-hydrogen bonds of the 6KZP-montelukast complex (blue) and 6KZP-native complex (orange colour). <strong>(C)</strong> Number of inter-hydrogen bonds for the 6KZP-montelukast complex. <strong>(D)</strong> Number of inter-hydrogen bonds for the 6KZP-native complex.</p></figcaption></figure><p>The 6KZP-montelukast complex has lower solvent accessible surface area (SASA) values than the 6KZP-native complex over the 100 ns MD simulation (<a href="#pone.0327386.g006" class="usa-link">Fig 6A</a>). The final SASA values of the 6KZP-montelukast and the 6KZP-native complexes are about 610 nm<sup>2</sup> and 520 nm<sup>2</sup>, respectively. A high SASA value indicates that a high proportion of the complex is surrounded by solvent molecules, whereas a low SASA value indicates that a large number of solvent molecules are buried inside the complex. Thus, the structure of the 6KZP-montelukast complex has less area covered by solvent molecules and is more compact and probably more stable than the 6KZP-native complex.</p>
<figure class="fig xbox font-sm" id="pone.0327386.g006"><h4 class="obj_head">Fig 6. (A) SASA and (B) interaction energies of the 6KZP-native complex (orange colour) and 6KZP-montelukast complex (blue).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334052_pone.0327386.g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46e/12334052/eb9e8d6bf295/pone.0327386.g006.jpg" loading="lazy" height="623" width="660" alt="Fig 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0327386.g006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>The interaction energy calculated by GROMACS is defined as the potential energy of the complex minus the sum of the potential energies of the protein and ligand. A negative interaction energy means that energy is released upon binding; thus, the complex is more stable than the individual protein and ligand. Here, the interaction energy of the 6KZP-montelukast complex stabilised at around −300 kJmol<sup>−1</sup> after about 20 ns simulation, whereas that of the 6KZP-native complex stabilised at around −200 kJmol<sup>−1</sup> after about 2 ns (<a href="#pone.0327386.g006" class="usa-link">Fig 6B</a>). The lower interaction energy of 6KZP-montelukast indicates a higher binding affinity and stability than the 6KZP-native.</p>
<p>The results of the Principal Component Analysis (PCA) show that the first two principal components (PCs) of the 6KZP-montelukast complex capture 61.2% of its total motion, requiring 8 PCs to account for 80.9%. In contrast, the first two PCs of the 6KZP-native complex capture 55.8% of its aggregate motion and require 12 PCs to explain 80.6%, indicating a more complex dynamic behaviour. This suggests that the 6KZP-montelukast complex has a more efficient representation of its dynamics, while the 6KZP-native complex exhibits greater complexity, necessitating more components for a comparable level of explanation.</p>
<p>In the 2D projections of trajectories (<a href="#pone.0327386.g007" class="usa-link">Fig 7A</a>), the clustered points correspond to similar conformations or states of the system, indicating shared structural features or dynamics. The 6KZP-native complex exhibits a greater number of smaller clusters, while the 6KZP-montelukast complex displays fewer but larger clusters, which may represent more stable states. Additionally, isolated points between these clusters may signify transient conformations.</p>
<figure class="fig xbox font-sm" id="pone.0327386.g007"><h4 class="obj_head">Fig 7. (A) Principal component analysis of the 2D projections of trajectories for the 6KZP-native complex and the 6KZP-montelukast complex.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334052_pone.0327386.g007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46e/12334052/956026328f78/pone.0327386.g007.jpg" loading="lazy" height="251" width="700" alt="Fig 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0327386.g007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Two-dimensional contour map of the Gibbs Free Energy Landscape (FEL) during 100 ns MD simulations for (B) the 6KZP-native complex and (C) the 6KZP-montelukast complex. The first and last principal components (PCs) indicate the components used to capture approximately 80% of the total dynamic motion. The 6KZP-montelukast complex requires 8 PCs, while the 6KZP-native complex requires 12 PCs.</p></figcaption></figure><p>The Gibbs Free Energy landscape for both the 6KZP-native complex and the 6KZP-montelukast complex was analysed during the 100 ns MD simulations, utilising the first and last principal components that account for approximately 80% of the data variations (<a href="#pone.0327386.g007" class="usa-link">Figs 7B</a> and <a href="#pone.0327386.g007" class="usa-link">C</a>). These landscapes illustrate the directional fluctuations of the C-alpha atoms, revealing a large region of low energy in both complexes, indicating high stability. Notably, the 6KZP-native complex displayed multiple low-energy minima (shown in blue), suggesting it may exist in several states. In contrast, the deep blue low-energy region of the 6KZP-montelukast complex is more concentrated in a single region, indicating fewer low-energy stable states.</p>
<p>In summary, both the docking and MD simulations indicate a high binding affinity between montelukast and Ca<sub>v</sub>3.1. This supports further study on the use of montelukast as a Ca<sub>v</sub>3.1 inhibitor for the treatment of neurological diseases, such as epileptic seizures.</p></section><section id="sec005"><h3 class="pmc_sec_title">Binding free energy calculations</h3>
<p>MMPBSA and MMGBSA binding free energy calculations were performed on the conformations of both Z944 and montelukast at the 100 ns MD simulations. The results from both approaches indicate that montelukast binds with a higher affinity than Z944, as evidenced by its lower binding free energies (<a href="#pone.0327386.t002" class="usa-link">Table 2</a>). This suggests that the binding complex of montelukast with Ca<sub>v</sub>3.1 is more stable than that of Z944. The increased stability primarily results from the van der Waals (<em>ΔE</em><sub><em>vdW</em></sub>) and electrostatic interaction energies (<em>ΔE</em><sub><em>elec</em></sub>), with differences of approximately 23.5 kcal/mol for van der Waals energy and 0.86 kcal/mol for electrostatic energy between montelukast and Z944. The total change in solvation free energy (<em>ΔG</em><sub><em>solv</em></sub>) for the montelukast complex is more positive than that of Z944, indicating that solvation is less favourable in the montelukast complex, which detracts from its binding affinity.</p>
<section class="tw xbox font-sm" id="pone.0327386.t002"><h4 class="obj_head">Table 2.  Binding free energy calculations between Ca<sub>v</sub>3.1 and its native ligand (Z944) or montelukast by MMPBSA and MMGBSA. <em>ΔE</em><sub>vdW</sub> represents the van der Waals energy, <em>ΔE</em><sub><em>elec</em></sub> denotes the electrostatic energy, <em>ΔE</em><sub><em>polar</em></sub> indicates the polar solvation energy, and <em>ΔG</em><sub><em>solv</em></sub> reflects the total change in solvation free energy. The “Binding” column presents the binding free energies. All energy values are expressed in kcal mol ⁻ ¹.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Ligand</th>
<th align="left" rowspan="1" colspan="1">∆<em>E</em><em>vdW</em>
</th>
<th align="left" rowspan="1" colspan="1">∆<em>E</em><em>elec</em>
</th>
<th align="left" rowspan="1" colspan="1">∆<em>E</em><sub><em>polar</em></sub>
</th>
<th align="left" rowspan="1" colspan="1">∆<em>G</em><em>solv</em>
</th>
<th align="left" rowspan="1" colspan="1">Binding</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>MMPBSA</strong><br>Native (Z944)</td>
<td align="left" rowspan="1" colspan="1">−44.15</td>
<td align="left" rowspan="1" colspan="1">−9.37</td>
<td align="left" rowspan="1" colspan="1">24.46</td>
<td align="left" rowspan="1" colspan="1">19.95</td>
<td align="left" rowspan="1" colspan="1">−33.57</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Montelukast</td>
<td align="left" rowspan="1" colspan="1">−67.67</td>
<td align="left" rowspan="1" colspan="1">−10.23</td>
<td align="left" rowspan="1" colspan="1">34.27</td>
<td align="left" rowspan="1" colspan="1">25.27</td>
<td align="left" rowspan="1" colspan="1">−52.62</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>MMGBSA</strong><br>Native (Z944)</td>
<td align="left" rowspan="1" colspan="1">−44.15</td>
<td align="left" rowspan="1" colspan="1">−9.37</td>
<td align="left" rowspan="1" colspan="1">28.47</td>
<td align="left" rowspan="1" colspan="1">22.73</td>
<td align="left" rowspan="1" colspan="1">−30.79</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Montelukast</td>
<td align="left" rowspan="1" colspan="1">−67.67</td>
<td align="left" rowspan="1" colspan="1">−10.23</td>
<td align="left" rowspan="1" colspan="1">39.30</td>
<td align="left" rowspan="1" colspan="1">32.83</td>
<td align="left" rowspan="1" colspan="1">−45.06</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0327386.t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec006"><h3 class="pmc_sec_title">Monte carlo cell (MCell) modelling</h3>
<p>A model utilising MCell and CellBlender was constructed to simulate the interaction between montelukast, calcium ions, Ca<sub>v</sub>3.1, synaptic active membrane, and synaptic vesicles in and around the pre-synapse. It incorporates the opening of Ca<sub>v</sub>3.1 channels near the pre-synaptic bouton, enabling the flow of calcium ions from the extracellular space into the pre-synapse. The influx of calcium ions can trigger the release of neurotransmitter molecules into the synaptic cleft, where they diffuse and initiate signal transmission in the postsynaptic cell. Excessive calcium influx can result in neurological disorders such as epileptic seizures. Conversely, if montelukast blocks the Ca<sub>v</sub>3.1 channels, it can reduce calcium entry and neurotransmitter release, potentially preventing such disorders.</p>
<p>In total, eight 0.2s MCell simulations were performed using different concentrations of montelukast and different rates of reaction (<em>k</em><sub><em>2</em></sub>) between montelukast and the calcium channel (<a href="#pone.0327386.t003" class="usa-link">Table 3</a>). The simulations demonstrated that the calcium ions and montelukast competed with the calcium channels. Once the montelukast molecules bound to the calcium channels, they blocked the movement of the calcium ions from the extra-synaptic region to the pre-synapse. This reduced the formation of the complex of calcium ions and synaptic vesicles in the pre-synapse, and thus reduced the amount of neurotransmitter released to the extra-synaptic region.</p>
<section class="tw xbox font-sm" id="pone.0327386.t003"><h4 class="obj_head">Table 3. The number of calcium ion and vesicle complexes located in the extra-synaptic region at 0.1 and 0.2 seconds in the MCell simulations under different <em>k</em><sub><em>2</em></sub> rate constants and initial number of montelukast.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Number of montelukast molecules</th>
<th align="left" rowspan="1" colspan="1">Rate <em>k</em><sub><em>2</em></sub><br>(M<sup>-1</sup>s<sup>-1</sup>)</th>
<th align="left" rowspan="1" colspan="1">Number of the calcium ion and vesicle complex at 0.1 second</th>
<th align="left" rowspan="1" colspan="1">Number of the calcium ion and vesicle complex at 0.2 seconds</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">0</td>
<td align="left" rowspan="1" colspan="1">NA</td>
<td align="left" rowspan="1" colspan="1">2312</td>
<td align="left" rowspan="1" colspan="1">2665</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">500</td>
<td align="left" rowspan="1" colspan="1">0.5 x 10<sup>6</sup>
</td>
<td align="left" rowspan="1" colspan="1">2313</td>
<td align="left" rowspan="1" colspan="1">2654</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">500</td>
<td align="left" rowspan="1" colspan="1">1.0 x 10<sup>7</sup>
</td>
<td align="left" rowspan="1" colspan="1">2289</td>
<td align="left" rowspan="1" colspan="1">2671</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">500</td>
<td align="left" rowspan="1" colspan="1">5.0 x 10<sup>7</sup>
</td>
<td align="left" rowspan="1" colspan="1">2271</td>
<td align="left" rowspan="1" colspan="1">2588</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">500</td>
<td align="left" rowspan="1" colspan="1">1.0 x 10<sup>8</sup>
</td>
<td align="left" rowspan="1" colspan="1">2164</td>
<td align="left" rowspan="1" colspan="1">2539</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">1500</td>
<td align="left" rowspan="1" colspan="1">0.5 x 10<sup>6</sup>
</td>
<td align="left" rowspan="1" colspan="1">2252</td>
<td align="left" rowspan="1" colspan="1">2612</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">1500</td>
<td align="left" rowspan="1" colspan="1">1.0 x 10<sup>7</sup>
</td>
<td align="left" rowspan="1" colspan="1">2239</td>
<td align="left" rowspan="1" colspan="1">2582</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">1500</td>
<td align="left" rowspan="1" colspan="1">5.0 x 10<sup>7</sup>
</td>
<td align="left" rowspan="1" colspan="1">1971</td>
<td align="left" rowspan="1" colspan="1">2262</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">1500</td>
<td align="left" rowspan="1" colspan="1">1.0 x 10<sup>8</sup>
</td>
<td align="left" rowspan="1" colspan="1">1750</td>
<td align="left" rowspan="1" colspan="1">1969</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0327386.t003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>The results of this study are as expected in our hypothesis. A high concentration of montelukast molecules and high <em>k</em><sub><em>2</em></sub> values reduced the number of vesicles docking with the presynaptic membrane and releasing neurotransmitter to the extra-synaptic region. There were about 26% fewer vesicles docking when 1,500 montelukast molecules were presented with a <em>k</em><sub><em>2</em></sub> value of 1.0 × 10<sup>8</sup> M<sup>-1</sup>s<sup>-1</sup> in the system compared to the absence of montelukast. In contrast, there was almost no change in the number of vesicles docking when comparing the simulation of 500 montelukast molecules with a <em>k</em><sub><em>2</em></sub> value of 0.5 × 10<sup>6</sup> M<sup>-1</sup>s<sup>-1</sup> and the absence of montelukast (<a href="#pone.0327386.t003" class="usa-link">Table 3</a>). When the amount of montelukast was set at 500 and the value of <em>k</em><sub><em>2</em></sub> increased from 0.5 × 10<sup>6</sup> M<sup>-1</sup>s<sup>-1</sup> to 1.0 × 10<sup>8</sup> M<sup>-1</sup>s<sup>-1</sup>, there was only a 4% increase in the number of vesicles being released. For the simulations with 1,500 montelukast, the number of vesicles being released increased by 24% when <em>k</em><sub><em>2</em></sub> increased from 0.5 × 10<sup>6</sup> M<sup>-1</sup>s<sup>-1</sup> to 1.0 × 10<sup>8</sup> M<sup>-1</sup>s<sup>-1</sup>. Thus, both the concentration of the montelukast and the <em>k</em><sub><em>2</em></sub> reaction rate are important factors in these simulations.</p>
<p><a href="#pone.0327386.g008" class="usa-link">Figs 8A</a> and <a href="#pone.0327386.g008" class="usa-link">B</a> show the MCell simulation results with the standard parameters, a <em>k</em><sub><em>2</em></sub> rate constant of 1.0 × 10<sup>8</sup> M<sup>-1</sup>s<sup>-1</sup>, with 1,500 montelukast molecules and with no montelukast molecules. The figures indicate that the calcium ions and montelukast compete with each other to bind to the calcium channel located in the extra-synaptic region. After 0.2 s of the simulation, the system was almost equilibrated, and about 700 montelukast molecules were bound to the calcium channels. This reduced the number of calcium ions that could bind to the channels, and thus the number of vesicles being released to the extra-synaptic region.</p>
<figure class="fig xbox font-sm" id="pone.0327386.g008"><h4 class="obj_head">Fig 8. Quantities of the items in the MCell simulations with standard parameters and: (A) 1,500 montelukast molecules and <em>k</em><sub><em>2</em></sub> = 1.0 × 10<sup>8</sup> M<sup>-1</sup>s<sup>-1</sup>; (B) no montelukast molecules and <em>k</em><sub><em>2</em></sub> = 1.0 × 10<sup>8</sup> M<sup>-1</sup>s<sup>-1</sup>; (C) 500 montelukast molecules and <em>k</em><sub><em>2</em></sub> = 1.0 × 10<sup>7</sup> M<sup>-1</sup>s<sup>-1</sup>; (D) 1,500 montelukast molecules and <em>k</em><sub><em>2</em></sub> = 1.0 × 10<sup>7</sup> M<sup>-1</sup>s<sup>-1</sup>; (E) 500 montelukast molecules and <em>k</em><sub><em>2</em></sub> = 0.5 × 10<sup>6</sup> M<sup>-1</sup>s<sup>-1</sup>; (F) 500 montelukast molecules and <em>k</em><sub><em>2</em></sub> = 1.0 × 10<sup>8</sup> M<sup>-1</sup>s<sup>-1</sup>.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334052_pone.0327386.g008.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46e/12334052/05251537a4ef/pone.0327386.g008.jpg" loading="lazy" height="590" width="660" alt="Fig 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0327386.g008/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>CA_CYT and CA_Pre are the calcium ions located in the extra-synaptic region and the pre-synapse, respectively. E_World is the complex of montelukast and calcium channels. Mont_World is the montelukast in the whole system, VesC_CYT and VesC_Pre are the complexes of calcium ions and vesicles located in the extra-synaptic region and the pre-synapse, respectively.</p></figcaption></figure><p><a href="#pone.0327386.g008" class="usa-link">Figs 8C</a> and <a href="#pone.0327386.g008" class="usa-link">D</a> show the simulations with the standard parameters, a <em>k</em><sub><em>2</em></sub> rate constant of 1.0 × 10<sup>7</sup> M<sup>-1</sup>s<sup>-1</sup> and with 500 and 1,500 montelukast molecules. Again, the systems seem to be almost equilibrated after 0.2 s. The number of calcium channels blocked by the montelukast increased gradually with time, leading to a reduction in the vesicles being released in the extra-synaptic region. <a href="#pone.0327386.g008" class="usa-link">Figs 8E</a> and <a href="#pone.0327386.g008" class="usa-link">F</a> illustrate that an increase of <em>k</em><sub><em>2</em></sub> rate constant from 0.5 × 10<sup>6</sup> M<sup>-1</sup>s<sup>-1</sup> to 1.0 × 10<sup>8</sup> M<sup>-1</sup>s<sup>-1</sup> for the system, with a small number of montelukast molecules (500), has a minimal effect on the number of vesicles being released. This may simply be because the lower reaction rate causes the montelukast to be less competitive than the calcium ions in binding to the channels.</p></section><section id="sec007"><h3 class="pmc_sec_title">Limitations</h3>
<p>Our results indicate that montelukast binding to Ca<sub>v</sub>3.1 is more stable than its native ligand Z944. Montelukast may have the ability to decrease the number of neurotransmitters released from the pre-synapse and potentially has therapeutic effects on neurological disorders, such as epileptic seizures. However, there are several limitations to this study.</p>
<p>The docking simulations in this study were conducted using the GOLD genetic docking algorithms and ChemPLP scoring functions, without employing multiple docking software for cross-validation. However, our successful ROC analysis, along with support from previous studies [<a href="#pone.0327386.ref030" class="usa-link" aria-describedby="pone.0327386.ref030">30</a>,<a href="#pone.0327386.ref031" class="usa-link" aria-describedby="pone.0327386.ref031">31</a>], indicates the high reliability of our docking results.</p>
<p>The selection of binding sites for ligands can influence docking scores. In this study, the binding pore domain of the native ligand, Z944, was used as the binding pocket for all docking simulations. While this is a standard practice, it does neglect the possibility that montelukast may have alternative binding sites <em>in vivo</em> or that allosteric sites may exist where multiple molecules of Montelukast can bind to different locations on Ca<sub>v</sub>3.1 simultaneously.</p>
<p>This study conducted 100 ns MD simulations, which have demonstrated that the protein-ligand complexes reached a stable state. Additionally, the 100 ns timescale is consistent with other studies of Ca<sub>v</sub>3.1 using the PDB code 6KZP [<a href="#pone.0327386.ref032" class="usa-link" aria-describedby="pone.0327386.ref032">32</a>–<a href="#pone.0327386.ref034" class="usa-link" aria-describedby="pone.0327386.ref034">34</a>]. However, there remains a possibility for the system to become unstable after a prolonged period of stability due to a sudden conformational change.</p>
<p>The use of Berendsen temperature coupling and Parrinello-Rahman barostat pressure coupling during NVT and NPT equilibration steps is primarily due to their simplicity and efficiency. The Berendsen thermostat is straightforward to implement in GROMACS and computationally efficient, making it suitable for initial equilibration steps. It also allows for rapid adjustments to the system’s temperature without introducing significant artifacts [<a href="#pone.0327386.ref035" class="usa-link" aria-describedby="pone.0327386.ref035">35</a>]. However, other approaches, such as the Nose-Hoover thermostat and Velocity Rescaling thermostat, generate a proper ensemble and provide more accurate temperature control [<a href="#pone.0327386.ref035" class="usa-link" aria-describedby="pone.0327386.ref035">35</a>]. Similarly, the Monte Carlo barostat and Martyna-Tuckerman-Tobias-Klein barostat offer accurate pressure control and are less prone to instability [<a href="#pone.0327386.ref035" class="usa-link" aria-describedby="pone.0327386.ref035">35</a>].</p>
<p>Docking and MD can only suggest that montelukast has a high binding affinity to Ca<sub>v</sub>3.1, but cannot indicate whether it is an inhibitor or an inducer. An inhibitor of Ca<sub>v</sub>3.1 may produce the therapeutic effects mentioned in this study. In contrast, an inducer of Ca<sub>v</sub>3.1 may increase the amount of calcium ion flux into the pre-synapse and increase signal transmission between neurons, thus worsening the condition of patients with neurological disorders, such as epileptic seizures. This indistinguishable property is the common drawback of docking and MD. However, most ligands are inhibitors, because induction requires activation of an enzyme, which generally requires conformational changes after binding, and only a very specific ligand structure can achieve this [<a href="#pone.0327386.ref036" class="usa-link" aria-describedby="pone.0327386.ref036">36</a>]. Thus, there is a high chance that montelukast is an inhibitor of Ca<sub>v</sub>3.1.</p>
<p>Other limitations that may affect the interpretation of the results of this study are the result of uncertain reaction rates and the simplification of the MCell model. The reaction rates of montelukast binding and blocking the calcium channel could not be found in the literature; thus, several different values were explored in this study. Although these rates were based on those of another calcium channel blocker, nifedipine [<a href="#pone.0327386.ref037" class="usa-link" aria-describedby="pone.0327386.ref037">37</a>], they may not be precisely appropriate for montelukast. Another limitation is that the exchange of ions and neurotransmitters within the synapse requires many different types of channels and diffusion mechanisms, and these are far more complicated than our model. There are also many organelles in the human pre-synapse region, and they may affect the diffusion of calcium ions, synaptic vesicles and neurotransmitters. Nevertheless, our MCell results successfully simulated the interaction of montelukast molecules with all other components in the synapse model and showed that montelukast molecules reduced the number of vesicle complexes released from the pre-synapse. Thus, we believe the negative effect of this limitation on the result is minimal.</p></section></section><section id="sec008"><h2 class="pmc_sec_title">Conclusions</h2>
<p>Montelukast is an FDA-approved drug that has been used for decades. It has the appropriate pharmacodynamics, pharmacokinetics and pharmacovigilance profile for long-term oral administration [<a href="#pone.0327386.ref019" class="usa-link" aria-describedby="pone.0327386.ref019">19</a>,<a href="#pone.0327386.ref021" class="usa-link" aria-describedby="pone.0327386.ref021">21</a>]. Montelukast is considered safe for use in pregnancy, while all other anti-epileptic drugs carry the risk of congenital malformation and adverse prenatal outcomes [<a href="#pone.0327386.ref021" class="usa-link" aria-describedby="pone.0327386.ref021">21</a>]. This study used molecular docking, MD and MCell simulations to illustrate the potential of montelukast in binding to the Ca<sub>v</sub>3.1 and reducing signal transmission between neurons. The results of this study support further <em>in vitro</em> investigations of montelukast as a safe and effective treatment for neurological diseases, such as epileptic seizures. The next step of this study is to perform an <em>in vitro</em> inhibition assay on Ca<sub>v</sub>3.1 and confirm the inhibition property of montelukast [<a href="#pone.0327386.ref038" class="usa-link" aria-describedby="pone.0327386.ref038">38</a>].</p></section><section id="sec009"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="sec010"><h3 class="pmc_sec_title">Molecular docking</h3>
<p>Molecular docking simulations were employed to calculate the binding affinities between Ca<sub>v</sub>3.1 and the 2,115 FDA-approved drugs of the ZINC database subset [<a href="#pone.0327386.ref009" class="usa-link" aria-describedby="pone.0327386.ref009">9</a>], aiming to identify a currently used drug that may inhibit the calcium channel. The 3-dimensional (3D) atomic coordinates of the sole Ca<sub>v</sub>3.1 structure derived from <em>Homo sapiens</em> in the Protein Data Bank, a ligand-bound Ca<sub>v</sub>3.1 (PDB code 6KZP), was retrieved [<a href="#pone.0327386.ref039" class="usa-link" aria-describedby="pone.0327386.ref039">39</a>]. This structure was previously determined by single particle cryogenic electron microscopy with 3.10 Å resolution [<a href="#pone.0327386.ref039" class="usa-link" aria-describedby="pone.0327386.ref039">39</a>]. The ligand bound to the structure was a Ca<sub>v</sub>3.1 selective antagonist, Z944, which was located in the central cavity of the pore domain (<a href="#pone.0327386.g001" class="usa-link">Fig 1</a>) [<a href="#pone.0327386.ref040" class="usa-link" aria-describedby="pone.0327386.ref040">40</a>]. This site is considered the binding pocket for all the docking simulations in this study. This structure has been used in several studies for Ca<sub>v</sub>3.1 channel simulations, including one that discovered a novel cyclic peptide as a Ca<sub>v</sub>3.1 channel inhibitor [<a href="#pone.0327386.ref034" class="usa-link" aria-describedby="pone.0327386.ref034">34</a>,<a href="#pone.0327386.ref041" class="usa-link" aria-describedby="pone.0327386.ref041">41</a>].</p>
<p>Many docking programs have been developed, each of which has its own set of docking algorithms, scoring functions, and optimisation methods, resulting in varying degrees of accuracy when applied to different protein-ligand systems [<a href="#pone.0327386.ref029" class="usa-link" aria-describedby="pone.0327386.ref029">29</a>]. The docking algorithm is used to search all the potential orientations and conformations of the ligand located in the binding site of the protein. The scoring function is used to calculate the binding energies or binding scores of all the potential orientations and conformations [<a href="#pone.0327386.ref042" class="usa-link" aria-describedby="pone.0327386.ref042">42</a>].</p>
<p>The automated docking suite GOLD v5.5 [<a href="#pone.0327386.ref043" class="usa-link" aria-describedby="pone.0327386.ref043">43</a>] was used for all docking simulations in this study. GOLD contains several docking algorithms and scoring functions for users to select. According to a previous study [<a href="#pone.0327386.ref043" class="usa-link" aria-describedby="pone.0327386.ref043">43</a>,<a href="#pone.0327386.ref044" class="usa-link" aria-describedby="pone.0327386.ref044">44</a>], the genetic algorithm of GOLD achieved an 80–90% success rate in finding the experimental binding modes of a dataset with 85 complexes, depending on the protocols used. ChemPLP achieved the highest success rate among 20 different scoring functions in a docking power test using a dataset of 195 protein-ligand complexes [<a href="#pone.0327386.ref031" class="usa-link" aria-describedby="pone.0327386.ref031">31</a>]. This combination of docking algorithm and scoring function has also been used for calcium channel docking simulations [<a href="#pone.0327386.ref030" class="usa-link" aria-describedby="pone.0327386.ref030">30</a>]. Therefore, in this study, the genetic algorithms with 100% search efficiency and the ChemPLP scoring function [<a href="#pone.0327386.ref045" class="usa-link" aria-describedby="pone.0327386.ref045">45</a>] of GOLD v5.5 were used for all docking simulations. The docking protocols were set with no early termination, and the ‘slow’ option with high accuracy and the default parameters were used. Atoms within an area of 6 Å of the cognate ligands (Z944) in the X-ray crystallographic structures were set as the binding sites (PDB code 6KZP).</p>
<p>To validate the accuracy of our docking protocols in simulating Ca<sub>v</sub>3.1 complexes, we performed a receiver operating characteristic (ROC) analysis. It has been used in various studies to evaluate the performance of docking simulations, mainly focusing on their ability to distinguish between the ‘true’ hits and the ‘negatives’ [<a href="#pone.0327386.ref046" class="usa-link" aria-describedby="pone.0327386.ref046">46</a>–<a href="#pone.0327386.ref048" class="usa-link" aria-describedby="pone.0327386.ref048">48</a>]. In the receiver operating characteristic analysis, the docking scores were used to plot the true positive rate against the false positive rate at various threshold settings. The true positive rate was calculated using the experimentally determined binding affinities from the Zinc-<em>in-vivo</em> (ZIV) database [<a href="#pone.0327386.ref009" class="usa-link" aria-describedby="pone.0327386.ref009">9</a>]. The area under the curve (AUC) was calculated to indicate the capability of the docking procedure in classifying the true hits from the whole dataset. An AUC value of 1.0 indicates a perfect classification model, and a value of 0.5 indicates a random model with no predictive power. In general, an AUC value of 0.7 or above means that the docking scores have acceptable predictive power in distinguishing between binders and non-binders to the protein [<a href="#pone.0327386.ref049" class="usa-link" aria-describedby="pone.0327386.ref049">49</a>].</p>
<p>The receiver operating characteristic analysis of this study used the docking scores between Ca<sub>v</sub>3.1 and 14,066 compounds in the ZIV database [<a href="#pone.0327386.ref009" class="usa-link" aria-describedby="pone.0327386.ref009">9</a>] as the ‘negatives’. These compounds are considered negative since they lack specific information indicating their status as T-type calcium channel inhibitors. Nonetheless, there is a possibility that a small subset of them retains the ability to bind to T-type calcium channels. Additionally, 548 T-type calcium channel inhibitors were obtained from the ZINC database as the ‘true’ hits. Thus, the total number of complexes used in this analysis was 14,614. All the compounds of the ZIV database have reported bioactivities in animals, including humans. The result of our analysis, shown in <a href="#pone.0327386.g009" class="usa-link">Fig 9</a>, indicates the satisfactory predictive power of our docking method. The high AUC value (0.865) indicates that the method has high sensitivity and specificity.</p>
<figure class="fig xbox font-sm" id="pone.0327386.g009"><h4 class="obj_head">Fig 9. Receiver operating characteristic curves of our docking simulations between Ca<sub>v</sub>3.1 (PDB code 6KZP) and the 14,614 compounds obtained from the ZIV database and the ZINC database.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46e/12334052/b4c7d46e47d1/pone.0327386.g009.jpg" loading="lazy" height="599" width="600" alt="Fig 9"></p>
<div class="p text-right font-secondary"><a href="figure/pone.0327386.g009/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The red line is a reference line, which indicates no predictive power, and the blue line is the resulting curve with an AUC value of 0.865.</p></figcaption></figure></section><section id="sec011"><h3 class="pmc_sec_title">Molecular dynamics (MD)</h3>
<p>The aim of performing MD was to validate the docking results and to investigate protein-ligand dynamic interactions. MD simulates the motions and flexibility of a protein-ligand complex over a period of time, rather than a set of conformations as in the docking simulation. Thus, MD is more computationally demanding than docking and generally requires a high-performance computer. In this study, the ECDF Linux Compute Cluster (Eddie) of the University of Edinburgh with GPU acceleration was used to perform 100 ns MD simulations with a 2 ps time step between the Ca<sub>v</sub>3.1 channel (PDB code 6KZP) and Z944 or the selected FDA-approved drug.</p>
<p>In this study, utilities from the GROMACS suite [<a href="#pone.0327386.ref050" class="usa-link" aria-describedby="pone.0327386.ref050">50</a>] were used for all MD simulations and analyses. We used ‘gmx mdrun’ for MD simulations [<a href="#pone.0327386.ref050" class="usa-link" aria-describedby="pone.0327386.ref050">50</a>], ‘gmx rms’ to calculate the root mean square deviations (RMSD) of the Ca<sub>v</sub>3.1 backbone associated with ligand-Ca<sub>v</sub>3.1 complex, ‘gmx rmsf’ to calculate the root mean square fluctuation (RMSF) of the protein amino acid residues, ‘gmx gyrate’ for the radius of gyration (Rg), ‘gmx sasa’ to estimate the solvent accessible surface area (SASA) [<a href="#pone.0327386.ref051" class="usa-link" aria-describedby="pone.0327386.ref051">51</a>], ‘gmx hbond’ to count the number of hydrogen bonds, and ‘gmx energy’ to calculate the interaction energies between the protein and ligands.</p>
<p>The atom types and parameters of the Ca<sub>v</sub>3.1 channel were generated using the CHARMM36 force field [<a href="#pone.0327386.ref052" class="usa-link" aria-describedby="pone.0327386.ref052">52</a>]. The parameterisation of the selected drug molecule (montelukast) was conducted using the CGenFF [<a href="#pone.0327386.ref053" class="usa-link" aria-describedby="pone.0327386.ref053">53</a>,<a href="#pone.0327386.ref054" class="usa-link" aria-describedby="pone.0327386.ref054">54</a>], which is accessible through the official CHARMM General Force Field server (<a href="https://cgenff.com/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://cgenff.com/</a>). The TIP3P water model was introduced to the system in a cubic unit cell shape [<a href="#pone.0327386.ref055" class="usa-link" aria-describedby="pone.0327386.ref055">55</a>]. Anions (<em>Cl</em><sup><em>–</em></sup>) were also added to neutralise the overall charge of the system. This ensures proper representation of electrostatic interactions and satisfactory system stability, preventing artificial polarisation, water distribution imbalance, and long-range interactions. This is a conventional practice in MD for more realistic and reliable simulations of protein-ligand complexes.Energy minimisation was performed on the system, to determine a molecular arrangement of all atoms that avoids steric clashes, using the steepest descent minimisation with 5 × 10<sup>4</sup> steps. After minimisation of the solvated and electroneutral system, equilibration was performed to ensure that the solvent and ions around the protein-ligand system have the appropriate molecular geometry at a suitable pressure, volume and temperature [<a href="#pone.0327386.ref056" class="usa-link" aria-describedby="pone.0327386.ref056">56</a>]. In general, equilibration contains two phases: the constant number of particles, volume and temperature (NVT) equilibration and the constant number of particles, pressure and temperature (NPT) equilibration. In this study, both NVT and NPT were performed for 5 ns with a 0.2 ps time step, while the protein and ligand were positionally restrained. The Berendsen temperature coupling method and Parrinello-Rahman barostat pressure coupling method were used to maintain the system at 300K and 1 bar [<a href="#pone.0327386.ref050" class="usa-link" aria-describedby="pone.0327386.ref050">50</a>]. These techniques approximate the physiological temperature and atmospheric pressure for realistic conditions for the simulation [<a href="#pone.0327386.ref050" class="usa-link" aria-describedby="pone.0327386.ref050">50</a>]. The Lennard-Jones potential was used to estimate the short-range interaction with a cut-off value of 12 Å. The long-range interactions were calculated by the Particle Mesh Ewald (PME) method, which has been shown to have an appropriate balance between computational cost and scientific reliability [<a href="#pone.0327386.ref057" class="usa-link" aria-describedby="pone.0327386.ref057">57</a>].</p>
<p>Previous studies have successfully utilised both the AMBER ff19SB force field and the CHARMM36m force field to simulate Ca<sub>v</sub>3.1 with the same protein structure (PDB code 6KZP) as in this study [<a href="#pone.0327386.ref032" class="usa-link" aria-describedby="pone.0327386.ref032">32</a>,<a href="#pone.0327386.ref033" class="usa-link" aria-describedby="pone.0327386.ref033">33</a>]. There is currently no literature comparing the accuracies or efficiencies of these two force fields for this specific protein. Therefore, we employed both in this study: AMBER for the Binding Free Energy calculations and CHARMM36 for the MD simulations. This approach enhances our confidence that if both force fields indicate that montelukast is more stable than the native inhibitor (Z944), we are likely to achieve accurate results.</p>
<p>After the MD simulations, Principal Component Analysis (PCA) and Free Energy Landscape (FEL) analyses were performed on both the Cav3.1 complexes of montelukast and the native (Z944) using the GROMACS functions ‘covar,’ ‘anaeig,’ and ‘sham’ [<a href="#pone.0327386.ref058" class="usa-link" aria-describedby="pone.0327386.ref058">58</a>]. These analyses capture crucial dynamic information from the simulation trajectories by simplifying the data’s complexity and highlighting the primary motion patterns in the system [<a href="#pone.0327386.ref058" class="usa-link" aria-describedby="pone.0327386.ref058">58</a>]. They are particularly beneficial for investigations focused on large-scale motions and conformational changes.</p></section><section id="sec012"><h3 class="pmc_sec_title">Binding free energy calculations</h3>
<p>The docking and molecular dynamics simulations may not accurately simulate solvation energy, which reflects the energy associated with interactions between the protein-ligand complex and water molecules. This limitation arises due to the high computational demands of such simulations, making it impractical to calculate solvation energies during large database screenings in docking or over extended MD simulations. Nevertheless, solvation energies can significantly influence the rate and magnitude of binding between a protein and a ligand [<a href="#pone.0327386.ref048" class="usa-link" aria-describedby="pone.0327386.ref048">48</a>]. Therefore, we employed molecular mechanics energies combined with the Poisson–Boltzmann (MMPBSA) and generalised Born and surface area continuum solvation (MMGBSA) approaches to calculate the binding free energies of the protein-ligand complex conformations at the 100 ns MD simulations, with the aim of assessing their stability [<a href="#pone.0327386.ref059" class="usa-link" aria-describedby="pone.0327386.ref059">59</a>].</p>
<p>A study by Sun <em>et al.</em> compared the performance of MMPBSA and MMGBSA in estimating binding free energies in 1,800 protein-ligand systems [<a href="#pone.0327386.ref060" class="usa-link" aria-describedby="pone.0327386.ref060">60</a>]. Both approaches had similar performance: the authors judged that MMGBSA was more useful in ranking individual ligands on multiple proteins, while MMPBSA was more appropriate for ranking multiple ligands on the same protein [<a href="#pone.0327386.ref060" class="usa-link" aria-describedby="pone.0327386.ref060">60</a>]. It is difficult to select which method is more appropriate for this study, which includes only two ligands (the native and the selected FDA-approved drug) and one protein (Ca<sub>v</sub>3.1). Thus, both methods were used here.</p>
<p>The gmx_MMPBSA function in GROMACS was utilised to calculate the binding free energy between Ca<sub>v</sub>3.1 and its native ligand (Z944) or montelukast [<a href="#pone.0327386.ref061" class="usa-link" aria-describedby="pone.0327386.ref061">61</a>]. The molecular mechanics (MM) component evaluated various interatomic interactions, including van der Waals and electrostatic forces. Solvation energy was determined by combining polar and non-polar contributions from the PBSA or GBSA models [<a href="#pone.0327386.ref061" class="usa-link" aria-describedby="pone.0327386.ref061">61</a>]. The binding free energy was derived from the difference between the energy of the complex and the sum of the energies of the unbound ligand and protein [<a href="#pone.0327386.ref061" class="usa-link" aria-describedby="pone.0327386.ref061">61</a>]. A more negative value indicates that more energy is released during binding, suggesting a more stable complex.</p></section><section id="sec013"><h3 class="pmc_sec_title">Monte carlo cell (MCell) modelling</h3>
<p>After performing docking and MD to determine the potential Ca<sub>v</sub>3.1 inhibitor from the 2,115 FDA-approved drugs, MCell modelling was conducted to simulate the interactions between the selected drug, calcium ions, Ca<sub>v</sub>3.1, synaptic active membrane and synaptic vesicles in and around the pre-synapse. In the human nervous system, when an action potential propagates into an axon, the Ca<sub>v</sub>3.1 channels close to the pre-synaptic bouton open and calcium ions from the extracellular space flow into the pre-synapse down the concentration gradient of calcium from the extra- to intra-presynapse. The calcium ions in the pre-synapse then trigger the synaptic vesicle to fuse with the pre-synaptic active membrane, and the neurotransmitter molecules in the synaptic vesicle are released into the synaptic cleft, where they diffuse, with some reaching postsynaptic receptors, initiating various forms of signal transmission in the postsynaptic cell. In particular, binding to ionotropic receptors such as AMPA or NMDA receptors leads to the influx of charge carried by ions into the postsynaptic cell. If the magnitude of this influx is too high, neurological disorders, such as epileptic seizures, may occur [<a href="#pone.0327386.ref001" class="usa-link" aria-describedby="pone.0327386.ref001">1</a>]. Blocking the Ca<sub>v</sub>3.1 channel with inhibitors may reduce the amount of calcium influx into the pre-synaptic region and decrease the number of neurotransmitter molecules being released. The resultant reduction in excitation may alleviate the severity of symptoms associated with neurological disorders.</p>
<p>This study employed an open-source 3D graphical software, CellBlender bundle version 4.0.5 with Blender 2.93, to create and visualise the synapse model. Blender is a software toolset that has been used to generate animated films, video editing, fluid dynamic simulations and more [<a href="#pone.0327386.ref062" class="usa-link" aria-describedby="pone.0327386.ref062">62</a>]. Thousands of add-ons have been developed for different purposes, including CellBlender, which is embedded with MCell (version 4.0.5) [<a href="#pone.0327386.ref063" class="usa-link" aria-describedby="pone.0327386.ref063">63</a>–<a href="#pone.0327386.ref065" class="usa-link" aria-describedby="pone.0327386.ref065">65</a>]. MCell is a comprehensive modelling environment that uses Monte Carlo Cell simulations to investigate the characteristics and geometries of particles and their reactions, including synaptic plasticity in dendritic spines [<a href="#pone.0327386.ref066" class="usa-link" aria-describedby="pone.0327386.ref066">66</a>–<a href="#pone.0327386.ref068" class="usa-link" aria-describedby="pone.0327386.ref068">68</a>].</p>
<p>The synapse model created in this study contains three parts: the pre-synapse, post-synapse and extracellular regions (<a href="#pone.0327386.g010" class="usa-link">Fig 10</a>). The volume and surface area of the pre-synapse region were 0.21 µm<sup>3</sup> and 2.27 µm<sup>2</sup>, respectively; those of the post-synapse region were 0.15 µm<sup>3</sup> and 2.13 µm<sup>2</sup>, and those of the extracellular region were 4.63 µm<sup>3</sup> and 16.04 µm<sup>2</sup>, respectively [<a href="#pone.0327386.ref069" class="usa-link" aria-describedby="pone.0327386.ref069">69</a>]. Calcium channels were placed on the upper surface of the pre-synapse, with a density of 104 per µm<sup>2</sup> (<a href="#pone.0327386.g010" class="usa-link">Fig 10C</a>) [<a href="#pone.0327386.ref069" class="usa-link" aria-describedby="pone.0327386.ref069">69</a>]. The bottom surface of the pre-synapse was assigned as an active membrane for the release of synaptic vesicles (<a href="#pone.0327386.g010" class="usa-link">Fig 10D</a>). These values were adopted from a recent study [<a href="#pone.0327386.ref069" class="usa-link" aria-describedby="pone.0327386.ref069">69</a>], which used MCell simulations to investigate the inhibition effects of gadolinium ions on calcium channels located on the pre-synapse.</p>
<figure class="fig xbox font-sm" id="pone.0327386.g010"><h4 class="obj_head">Fig 10. Model of synapse.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334052_pone.0327386.g010.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46e/12334052/d1e7a221b5cf/pone.0327386.g010.jpg" loading="lazy" height="301" width="660" alt="Fig 10"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0327386.g010/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>(A)</strong> The pre-synapse (top) and post-synapse (bottom); <strong>(B)</strong> The synapse model with calcium ions (green), montelukast (red), calcium channels (blue) and calcium pump (black); <strong>(C)</strong> The pre-synapse region (orange) where the calcium channels were located; <strong>(D)</strong> The pre-synapse region (orange) of the active membrane where the vesicle and calcium ion complexes were released.</p></figcaption></figure><p>Four reactions were used to describe the interactions between the selected FDA-approved drug, calcium ions and the synaptic vesicles in different compartments:</p>
<table class="disp-formula p" id="pone.0327386.e001"><tr>
<td class="formula"><math id="M1" display="block" overflow="linebreak"><mrow><msubsup><mrow><mi>C</mi><mi>a</mi></mrow><mrow><mi>o</mi><mi>u</mi><mi>t</mi></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msubsup><mo>+</mo><mi>A</mi><mover><mrow><mo>→</mo></mrow><mrow><msub><mi>k</mi><mrow><mn>1</mn></mrow></msub></mrow></mover><msubsup><mrow><mi>C</mi><mi>a</mi></mrow><mrow><mi>i</mi><mi>n</mi></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msubsup></mrow></math></td>
<td class="label">(1)</td>
</tr></table>
<table class="disp-formula p" id="pone.0327386.e002"><tr>
<td class="formula"><math id="M2" display="block" overflow="linebreak"><mrow><mi>M</mi><mo>+</mo><mi>A</mi><mover><mrow><mo>→</mo></mrow><mrow><msub><mi>k</mi><mrow><mn>2</mn></mrow></msub></mrow></mover><mi>E</mi></mrow></math></td>
<td class="label">(2)</td>
</tr></table>
<table class="disp-formula p" id="pone.0327386.e003"><tr>
<td class="formula"><math id="M3" display="block" overflow="linebreak"><mrow><msubsup><mrow><mi>C</mi><mi>a</mi></mrow><mrow><mi>i</mi><mi>n</mi></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msubsup><mo>+</mo><mi>V</mi><mover><mrow><mo>→</mo></mrow><mrow><msub><mi>k</mi><mrow><mn>3</mn></mrow></msub></mrow></mover><mi>D</mi></mrow></math></td>
<td class="label">(3)</td>
</tr></table>
<table class="disp-formula p" id="pone.0327386.e004"><tr>
<td class="formula"><math id="M4" display="block" overflow="linebreak"><mrow><msubsup><mrow><mi>C</mi><mi>a</mi></mrow><mrow><mi>i</mi><mi>n</mi></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msubsup><mo>+</mo><mi>P</mi><mover><mrow><mo>→</mo></mrow><mrow><msub><mi>k</mi><mrow><mn>4</mn></mrow></msub></mrow></mover><msubsup><mrow><mi>C</mi><mi>a</mi></mrow><mrow><mi>o</mi><mi>u</mi><mi>t</mi></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msubsup></mrow></math></td>
<td class="label">(4)</td>
</tr></table>
<p>where <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pone.0327386.e005"><math id="M5" display="inline" overflow="linebreak"><mrow><msubsup><mrow><mi>C</mi><mi>a</mi></mrow><mrow><mi>o</mi><mi>u</mi><mi>t</mi></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msubsup></mrow></math></span> and <span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="pone.0327386.e006"><math id="M6" display="inline" overflow="linebreak"><mrow><msubsup><mrow><mi>C</mi><mi>a</mi></mrow><mrow><mi>i</mi><mi>n</mi></mrow><mrow><mn>2</mn><mo>+</mo></mrow></msubsup></mrow></math></span> indicate the calcium ions located outside and inside the pre-synapse, respectively. The calcium channel (A) allows calcium ions to travel into the pre-synapse. Thus, <a href="#pone.0327386.e001" class="usa-link">equation 1</a> indicates the diffusion of calcium ions from the extracellular region into the pre-synapse through the calcium channels. <a href="#pone.0327386.e002" class="usa-link">Equation 2</a> indicates the selected FDA-approved drug M blocking the calcium channel (A) and forming a complex of the drug and calcium channel (E). V and D in <a href="#pone.0327386.e003" class="usa-link">equation 3</a> are the vesicles located inside the pre-synapse and the calcium ion and vesicle complex, respectively. In human pre-synapse, calcium ions are pumped out of the neurons by several mechanisms, such as ATP-driven pumps and Na<sup>+</sup>/Ca<sup>2+</sup> exchangers [<a href="#pone.0327386.ref070" class="usa-link" aria-describedby="pone.0327386.ref070">70</a>]. This study collectively calls all mechanisms that remove calcium ions ‘calcium pumps’. The P of <a href="#pone.0327386.e004" class="usa-link">equation 4</a> is the calcium pump that moves calcium ions out of the pre-synapse to the extracellular region.</p>
<p>The rate of calcium flux into the pre-synapse after binding to the calcium channel is denoted <em>k</em><sub><em>1</em></sub>. The rate at which the selected drug molecules bind and block the calcium channels is denoted <em>k</em><sub><em>2</em></sub>. The rate at which calcium ions bind to the vesicles inside the pre-synapse is denoted <em>k</em><sub><em>3</em></sub>. The rate of the calcium ions being pumped out of the pre-synapse is denoted <em>k</em><sub><em>4</em></sub>. The values of these rate constants (except <em>k</em><sub><em>2</em></sub>) were adopted from the study by Sutresno <em>et al</em>. [<a href="#pone.0327386.ref069" class="usa-link" aria-describedby="pone.0327386.ref069">69</a>] and are listed in <a href="#pone.0327386.t004" class="usa-link">Table 4</a>. As the rate constant <em>k</em><sub><em>2</em></sub> could not be found in the literature, we used four different values to explore the effects of the selected drug. According to the study by Mery <em>et al.</em> [<a href="#pone.0327386.ref037" class="usa-link" aria-describedby="pone.0327386.ref037">37</a>], the reaction rate constant of the calcium channel inhibitor nifedipine ranges from 1 × 10<sup>6</sup> to 4.47 × 10<sup>6</sup> M<sup>-1</sup>s<sup>-1</sup>. The docking results of this study (<a href="#pone.0327386.t001" class="usa-link">Table 1</a>) show that the docking scores of the selected drug and nifedipine were 100.71 and 47.78, respectively. Thus, we believe the reaction rate of the drug is higher than that of nifedipine, <em>i.e.</em>, at least 4.47 × 10<sup>6</sup> M<sup>-1</sup>s<sup>-1</sup>. We explored the effects of four different <em>k</em><sub><em>2</em></sub> values: 5 × 10<sup>6</sup> M<sup>-1</sup>s<sup>-1</sup>, 1 × 10<sup>7</sup> M<sup>-1</sup>s<sup>-1</sup>, 5 × 10<sup>7</sup> M<sup>-1</sup>s<sup>-1</sup> and 1 × 10<sup>8</sup> M<sup>-1</sup>s<sup>-1</sup> (<a href="#pone.0327386.t004" class="usa-link">Table 4</a>).</p>
<section class="tw xbox font-sm" id="pone.0327386.t004"><h4 class="obj_head">Table 4. Standard value of parameters in the MCell simulations.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Parameter</th>
<th align="left" rowspan="1" colspan="1">Standard Value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Rate <em>k</em><sub><em>1</em></sub>
</td>
<td align="left" rowspan="1" colspan="1">1.0 × 10<sup>8</sup> M<sup>-1</sup>s<sup>-1</sup>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rate <em>k</em><sub><em>2</em></sub>
</td>
<td align="left" rowspan="1" colspan="1">0.5 × 10<sup>6</sup>, 1.0 × 10<sup>7</sup>, 5.0 × 10<sup>7</sup>, 1.0 × 10<sup>8</sup> M<sup>-1</sup>s<sup>-1</sup>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rate <em>k</em><sub><em>3</em></sub>
</td>
<td align="left" rowspan="1" colspan="1">1.0 × 10<sup>7</sup> M<sup>-1</sup>s<sup>-1</sup>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rate <em>k</em><sub><em>4</em></sub>
</td>
<td align="left" rowspan="1" colspan="1">1.0 × 10<sup>7</sup> M<sup>-1</sup>s<sup>-1</sup>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Diffusion coefficient of calcium ions outside and inside the presynaptic</td>
<td align="left" rowspan="1" colspan="1">6.0 × 10<sup> − 6</sup> cm<sup>-1</sup>s<sup>-1</sup>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Diffusion coefficient of montelukast</td>
<td align="left" rowspan="1" colspan="1">1.0 × 10<sup> − 6</sup> cm<sup>-1</sup>s<sup>-1</sup>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Diffusion coefficient of vesicles</td>
<td align="left" rowspan="1" colspan="1">1.2 × 10<sup> − 6</sup> cm<sup>-1</sup>s<sup>-1</sup>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Diffusion coefficient of the calcium ion and the vesicle complex</td>
<td align="left" rowspan="1" colspan="1">1.0 × 10<sup> − 6</sup> cm<sup>-1</sup>s<sup>-1</sup>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Calcium channel density</td>
<td align="left" rowspan="1" colspan="1">1.0 × 10<sup>4</sup>
<em>µ</em>m<sup>2</sup>
</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Calcium pump density</td>
<td align="left" rowspan="1" colspan="1">1.0 × 10<sup>4</sup>
<em>µ</em>m<sup>2</sup>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0327386.t004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>In addition to the rate constant, the diffusion coefficient is also an important factor in our simulations. The diffusion coefficient indicates the distance that a molecule diffuses in the medium per unit of time. The diffusion coefficient values used in this study (<a href="#pone.0327386.t004" class="usa-link">Table 4</a>) were adopted from a previous study [<a href="#pone.0327386.ref069" class="usa-link" aria-describedby="pone.0327386.ref069">69</a>], which simulated the interaction between calcium ions and gadolinium ions within calcium channels that regulate entry into the pre-synapse. Two different ratios of the number of calcium ions and the selected drug were used: 6:1 (<em>N </em>= 3000 and 500) and 2:1 (<em>N</em> = 3000 and 1500). Again, these ratios were adopted from the study by Sutresno <em>et al.</em> [<a href="#pone.0327386.ref069" class="usa-link" aria-describedby="pone.0327386.ref069">69</a>]. These ratios are a rough estimation because no such data can be found in the literature.</p>
<p>The simulation protocol of this study is also similar to that of Sutresno <em>et al.</em> [<a href="#pone.0327386.ref069" class="usa-link" aria-describedby="pone.0327386.ref069">69</a>]: all the calcium channels were in their open states, and they were ready for binding to either the calcium ion or the FDA-approved drug molecule. As no information can be found in the literature with regard to how long the drug molecule could bind to the calcium channel, we simulated that neither the calcium ion nor the drug molecule would unbind from the calcium channel once binding occurs. We initialised the system with a specified number of calcium ions and drug molecules evenly distributed throughout the extra-synaptic region. The drug molecules competed for the calcium channels until they were all occupied.</p>
<p>In summary, this MCell model illustrates the effect of the selected drug on the inhibition of calcium channels. Its effect on the number of calcium ions in different compartments and the number of vesicles being released into the synaptic cleft under different reaction rate constants, diffusion constants and number of drug molecules was also demonstrated. The overall research process is summarised in <a href="#pone.0327386.g011" class="usa-link">Fig 11</a>.</p>
<figure class="fig xbox font-sm" id="pone.0327386.g011"><h4 class="obj_head">Fig 11. Overview of the research process.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12334052_pone.0327386.g011.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e46e/12334052/84c09a07a8be/pone.0327386.g011.jpg" loading="lazy" height="395" width="700" alt="Fig 11"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0327386.g011/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We are grateful to the National Center for Multiscale Modeling of Biological Systems (MMBios) of the University of Pittsburgh for teaching the authors to build MCell models. Susana Roman Garcia was supported by funding from Medical Research Scotland and CERN openlab (PHD-50053–2019).</p></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>All relevant data are within the paper and available on Zenodo at <a href="https://doi.org/10.5281/zenodo.13831314" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.5281/zenodo.13831314</a>.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The author(s) received no specific funding for this work.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0327386.ref001">
<span class="label">1.</span><cite>Belardetti F, Zamponi GW. Calcium channels as therapeutic targets. WIREs Membr Transp Signal. 2012;1(4):433–51. doi: 10.1002/wmts.38</cite> [<a href="https://doi.org/10.1002/wmts.38" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=WIREs%20Membr%20Transp%20Signal&amp;title=Calcium%20channels%20as%20therapeutic%20targets&amp;author=F%20Belardetti&amp;author=GW%20Zamponi&amp;volume=1&amp;issue=4&amp;publication_year=2012&amp;pages=433-51&amp;doi=10.1002/wmts.38&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref002">
<span class="label">2.</span><cite>Brinzeu A, Berthiller J, Caillet J, Staquet H, Mertens P. Ziconotide for spinal cord injury‐related pain. European Journal of Pain. 2019;23(9):1688–700. doi: 10.1002/ejp.1445
</cite> [<a href="https://doi.org/10.1002/ejp.1445" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31233255/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Pain&amp;title=Ziconotide%20for%20spinal%20cord%20injury%E2%80%90related%20pain&amp;author=A%20Brinzeu&amp;author=J%20Berthiller&amp;author=J%20Caillet&amp;author=H%20Staquet&amp;author=P%20Mertens&amp;volume=23&amp;issue=9&amp;publication_year=2019&amp;pages=1688-700&amp;pmid=31233255&amp;doi=10.1002/ejp.1445&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref003">
<span class="label">3.</span><cite>Zhu J, Chen N, Zhou M, Guo J, Zhu C, Zhou J, et al. Calcium channel blockers versus other classes of drugs for hypertension. Cochrane Database of Systematic Reviews. 2021;2021(10). doi: 10.1002/14651858.cd003654.pub5</cite> [<a href="https://doi.org/10.1002/14651858.cd003654.pub5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8520697/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34657281/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cochrane%20Database%20of%20Systematic%20Reviews&amp;title=Calcium%20channel%20blockers%20versus%20other%20classes%20of%20drugs%20for%20hypertension&amp;author=J%20Zhu&amp;author=N%20Chen&amp;author=M%20Zhou&amp;author=J%20Guo&amp;author=C%20Zhu&amp;volume=2021&amp;issue=10&amp;publication_year=2021&amp;pmid=34657281&amp;doi=10.1002/14651858.cd003654.pub5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref004">
<span class="label">4.</span><cite>Kopecky BJ, Liang R, Bao J. T-type calcium channel blockers as neuroprotective agents. Pflugers Arch - Eur J Physiol. 2014;466(4):757–65. doi: 10.1007/s00424-014-1454-x
</cite> [<a href="https://doi.org/10.1007/s00424-014-1454-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4005039/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24563219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pflugers%20Arch%20-%20Eur%20J%20Physiol&amp;title=T-type%20calcium%20channel%20blockers%20as%20neuroprotective%20agents&amp;author=BJ%20Kopecky&amp;author=R%20Liang&amp;author=J%20Bao&amp;volume=466&amp;issue=4&amp;publication_year=2014&amp;pages=757-65&amp;pmid=24563219&amp;doi=10.1007/s00424-014-1454-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref005">
<span class="label">5.</span><cite>Lory P, Nicole S, Monteil A. Neuronal Cav3 channelopathies: recent progress and perspectives. Pflugers Arch - Eur J Physiol. 2020;472(7):831–44. doi: 10.1007/s00424-020-02429-7
</cite> [<a href="https://doi.org/10.1007/s00424-020-02429-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7351805/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32638069/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pflugers%20Arch%20-%20Eur%20J%20Physiol&amp;title=Neuronal%20Cav3%20channelopathies:%20recent%20progress%20and%20perspectives&amp;author=P%20Lory&amp;author=S%20Nicole&amp;author=A%20Monteil&amp;volume=472&amp;issue=7&amp;publication_year=2020&amp;pages=831-44&amp;pmid=32638069&amp;doi=10.1007/s00424-020-02429-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref006">
<span class="label">6.</span><cite>Heron SE, Khosravani H, Varela D, Bladen C, Williams TC, Newman MR, et al. Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants. Annals of Neurology. 2007;62(6):560–8. doi: 10.1002/ana.21169
</cite> [<a href="https://doi.org/10.1002/ana.21169" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17696120/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Neurology&amp;title=Extended%20spectrum%20of%20idiopathic%20generalized%20epilepsies%20associated%20with%20CACNA1H%20functional%20variants&amp;author=SE%20Heron&amp;author=H%20Khosravani&amp;author=D%20Varela&amp;author=C%20Bladen&amp;author=TC%20Williams&amp;volume=62&amp;issue=6&amp;publication_year=2007&amp;pages=560-8&amp;pmid=17696120&amp;doi=10.1002/ana.21169&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref007">
<span class="label">7.</span><cite>Astori S, Wimmer RD, Prosser HM, Corti C, Corsi M, Liaudet N, et al. The Ca V 3.3 calcium channel is the major sleep spindle pacemaker in thalamus. Proc Natl Acad Sci USA. 2011;108(33):13823–8. doi: 10.1073/pnas.1105115108
</cite> [<a href="https://doi.org/10.1073/pnas.1105115108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3158184/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21808016/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20USA&amp;title=The%20Ca%20V%203.3%20calcium%20channel%20is%20the%20major%20sleep%20spindle%20pacemaker%20in%20thalamus&amp;author=S%20Astori&amp;author=RD%20Wimmer&amp;author=HM%20Prosser&amp;author=C%20Corti&amp;author=M%20Corsi&amp;volume=108&amp;issue=33&amp;publication_year=2011&amp;pages=13823-8&amp;pmid=21808016&amp;doi=10.1073/pnas.1105115108&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref008">
<span class="label">8.</span><cite>Bruno A, Costantino G, Sartori L, Radi M. The In Silico Drug Discovery Toolbox: Applications in Lead Discovery and Optimization. CMC. 2019;26(21):3838–73. doi: 10.2174/0929867324666171107101035</cite> [<a href="https://doi.org/10.2174/0929867324666171107101035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29110597/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CMC&amp;title=The%20In%20Silico%20Drug%20Discovery%20Toolbox:%20Applications%20in%20Lead%20Discovery%20and%20Optimization&amp;author=A%20Bruno&amp;author=G%20Costantino&amp;author=L%20Sartori&amp;author=M%20Radi&amp;volume=26&amp;issue=21&amp;publication_year=2019&amp;pages=3838-73&amp;pmid=29110597&amp;doi=10.2174/0929867324666171107101035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref009">
<span class="label">9.</span><cite>Irwin JJ, Tang KG, Young J, Dandarchuluun C, Wong BR, Khurelbaatar M, et al. ZINC20—A Free Ultralarge-Scale Chemical Database for Ligand Discovery. J Chem Inf Model. 2020;60(12):6065–73. doi: 10.1021/acs.jcim.0c00675
</cite> [<a href="https://doi.org/10.1021/acs.jcim.0c00675" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8284596/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33118813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Chem%20Inf%20Model&amp;title=ZINC20%E2%80%94A%20Free%20Ultralarge-Scale%20Chemical%20Database%20for%20Ligand%20Discovery&amp;author=JJ%20Irwin&amp;author=KG%20Tang&amp;author=J%20Young&amp;author=C%20Dandarchuluun&amp;author=BR%20Wong&amp;volume=60&amp;issue=12&amp;publication_year=2020&amp;pages=6065-73&amp;pmid=33118813&amp;doi=10.1021/acs.jcim.0c00675&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref010">
<span class="label">10.</span><cite>Sohlenius-Sternbeck A-K, Terelius Y. Evaluation of ADMET Predictor in Early Discovery Drug Metabolism and Pharmacokinetics Project Work. Drug Metabolism and Disposition. 2022;50(2):95–104. doi: 10.1124/dmd.121.000552
</cite> [<a href="https://doi.org/10.1124/dmd.121.000552" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34750195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Metabolism%20and%20Disposition&amp;title=Evaluation%20of%20ADMET%20Predictor%20in%20Early%20Discovery%20Drug%20Metabolism%20and%20Pharmacokinetics%20Project%20Work&amp;author=A-K%20Sohlenius-Sternbeck&amp;author=Y%20Terelius&amp;volume=50&amp;issue=2&amp;publication_year=2022&amp;pages=95-104&amp;pmid=34750195&amp;doi=10.1124/dmd.121.000552&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref011">
<span class="label">11.</span><cite>Brayfield A, Cadart C. Martindale: The Complete Drug Reference. 41 ed. London: Pharmaceutical Press. 2024.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Martindale:%20The%20Complete%20Drug%20Reference&amp;author=A%20Brayfield&amp;author=C%20Cadart&amp;publication_year=2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref012">
<span class="label">12.</span><cite>Reinhart MB, Huntington CR, Blair LJ, Heniford BT, Augenstein VA. Indocyanine Green. Surg Innov. 2015;23(2):166–75. doi: 10.1177/1553350615604053
</cite> [<a href="https://doi.org/10.1177/1553350615604053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26359355/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Surg%20Innov&amp;title=Indocyanine%20Green&amp;author=MB%20Reinhart&amp;author=CR%20Huntington&amp;author=LJ%20Blair&amp;author=BT%20Heniford&amp;author=VA%20Augenstein&amp;volume=23&amp;issue=2&amp;publication_year=2015&amp;pages=166-75&amp;pmid=26359355&amp;doi=10.1177/1553350615604053&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref013">
<span class="label">13.</span><cite>Xu L, Liu H, Murray BP, Callebaut C, Lee MS, Hong A, et al. Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer. ACS Med Chem Lett. 2010;1(5):209–13. doi: 10.1021/ml1000257
</cite> [<a href="https://doi.org/10.1021/ml1000257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4007915/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24900196/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Med%20Chem%20Lett&amp;title=Cobicistat%20(GS-9350):%20A%20Potent%20and%20Selective%20Inhibitor%20of%20Human%20CYP3A%20as%20a%20Novel%20Pharmacoenhancer&amp;author=L%20Xu&amp;author=H%20Liu&amp;author=BP%20Murray&amp;author=C%20Callebaut&amp;author=MS%20Lee&amp;volume=1&amp;issue=5&amp;publication_year=2010&amp;pages=209-13&amp;pmid=24900196&amp;doi=10.1021/ml1000257&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref014">
<span class="label">14.</span><cite>Wensing AM, Calvez V, Ceccherini-Silberstein F, Charpentier C, Günthard HF, Paredes R, et al. 2019. 
Update of the Drug Resistance Mutations in HIV-1. Top Antivir Med. 2019;27: 111–21.
</cite> [<a href="/articles/PMC6892618/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31634862/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Top%20Antivir%20Med&amp;title=Update%20of%20the%20Drug%20Resistance%20Mutations%20in%20HIV-1&amp;author=AM%20Wensing&amp;author=V%20Calvez&amp;author=F%20Ceccherini-Silberstein&amp;author=C%20Charpentier&amp;author=HF%20G%C3%BCnthard&amp;volume=27&amp;publication_year=2019&amp;pages=111-21&amp;pmid=31634862&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref015">
<span class="label">15.</span><cite>Diaz GA, Schulze A, Longo N, Rhead W, Feigenbaum A, Wong D, et al. Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients. Molecular Genetics and Metabolism. 2019;127(4):336–45. doi: 10.1016/j.ymgme.2019.07.004
</cite> [<a href="https://doi.org/10.1016/j.ymgme.2019.07.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31326288/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Genetics%20and%20Metabolism&amp;title=Long-term%20safety%20and%20efficacy%20of%20glycerol%20phenylbutyrate%20for%20the%20management%20of%20urea%20cycle%20disorder%20patients&amp;author=GA%20Diaz&amp;author=A%20Schulze&amp;author=N%20Longo&amp;author=W%20Rhead&amp;author=A%20Feigenbaum&amp;volume=127&amp;issue=4&amp;publication_year=2019&amp;pages=336-45&amp;pmid=31326288&amp;doi=10.1016/j.ymgme.2019.07.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref016">
<span class="label">16.</span><cite>Mushtaq A, Kapoor V, Latif A, Iftikhar A, Zahid U, McBride A, et al. Efficacy and toxicity profile of carfilzomib based regimens for treatment of multiple myeloma: A systematic review. Critical Reviews in Oncology/Hematology. 2018;125:1–11. doi: 10.1016/j.critrevonc.2018.02.008
</cite> [<a href="https://doi.org/10.1016/j.critrevonc.2018.02.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5901887/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29650268/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Critical%20Reviews%20in%20Oncology/Hematology&amp;title=Efficacy%20and%20toxicity%20profile%20of%20carfilzomib%20based%20regimens%20for%20treatment%20of%20multiple%20myeloma:%20A%20systematic%20review&amp;author=A%20Mushtaq&amp;author=V%20Kapoor&amp;author=A%20Latif&amp;author=A%20Iftikhar&amp;author=U%20Zahid&amp;volume=125&amp;publication_year=2018&amp;pages=1-11&amp;pmid=29650268&amp;doi=10.1016/j.critrevonc.2018.02.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref017">
<span class="label">17.</span><cite>Lin S, Wang Y, Zhang L, Guan W. &lt;p&gt;Dabigatran must be used carefully: literature review and recommendations for management of adverse events&lt;/p&gt;. DDDT. 2019;Volume 13:1527–33. doi: 10.2147/dddt.s203112
</cite> [<a href="https://doi.org/10.2147/dddt.s203112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6511609/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31190734/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=DDDT&amp;title=&lt;p&gt;Dabigatran%20must%20be%20used%20carefully:%20literature%20review%20and%20recommendations%20for%20management%20of%20adverse%20events&lt;/p&gt;&amp;author=S%20Lin&amp;author=Y%20Wang&amp;author=L%20Zhang&amp;author=W%20Guan&amp;publication_year=2019&amp;pages=1527-33&amp;pmid=31190734&amp;doi=10.2147/dddt.s203112&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref018">
<span class="label">18.</span><cite>Lee YJ, Kim C-K. Montelukast use over the past 20 years: monitoring of its effects and safety issues. Clin Exp Pediatr. 2020;63(10):376–81. doi: 10.3345/cep.2019.00325
</cite> [<a href="https://doi.org/10.3345/cep.2019.00325" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7568952/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32023405/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Exp%20Pediatr&amp;title=Montelukast%20use%20over%20the%20past%2020%20years:%20monitoring%20of%20its%20effects%20and%20safety%20issues&amp;author=YJ%20Lee&amp;author=C-K%20Kim&amp;volume=63&amp;issue=10&amp;publication_year=2020&amp;pages=376-81&amp;pmid=32023405&amp;doi=10.3345/cep.2019.00325&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref019">
<span class="label">19.</span><cite>Hatakeyama S, Goto M, Yamamoto A, Ogura J, Watanabe N, Tsutsumi S, et al. The safety of pranlukast and montelukast during the first trimester of pregnancy: A prospective, two‐centered cohort study in Japan. Congenital Anomalies. 2022;62(4):161–8. doi: 10.1111/cga.12471
</cite> [<a href="https://doi.org/10.1111/cga.12471" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35538631/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Congenital%20Anomalies&amp;title=The%20safety%20of%20pranlukast%20and%20montelukast%20during%20the%20first%20trimester%20of%20pregnancy:%20A%20prospective,%20two%E2%80%90centered%20cohort%20study%20in%20Japan&amp;author=S%20Hatakeyama&amp;author=M%20Goto&amp;author=A%20Yamamoto&amp;author=J%20Ogura&amp;author=N%20Watanabe&amp;volume=62&amp;issue=4&amp;publication_year=2022&amp;pages=161-8&amp;pmid=35538631&amp;doi=10.1111/cga.12471&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref020">
<span class="label">20.</span><cite>Sarkar M, Koren G, Kalra S, Ying A, Smorlesi C, De Santis M, et al. Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomes. Eur J Clin Pharmacol. 2009;65(12):1259–64. doi: 10.1007/s00228-009-0713-9
</cite> [<a href="https://doi.org/10.1007/s00228-009-0713-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19707749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Clin%20Pharmacol&amp;title=Montelukast%20use%20during%20pregnancy:%20a%20multicentre,%20prospective,%20comparative%20study%20of%20infant%20outcomes&amp;author=M%20Sarkar&amp;author=G%20Koren&amp;author=S%20Kalra&amp;author=A%20Ying&amp;author=C%20Smorlesi&amp;volume=65&amp;issue=12&amp;publication_year=2009&amp;pages=1259-64&amp;pmid=19707749&amp;doi=10.1007/s00228-009-0713-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref021">
<span class="label">21.</span><cite>Veroniki AA, Cogo E, Rios P, Straus SE, Finkelstein Y, Kealey R, et al. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med. 2017;15(1). doi: 10.1186/s12916-017-0845-1</cite> [<a href="https://doi.org/10.1186/s12916-017-0845-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5418725/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28472982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Med&amp;title=Comparative%20safety%20of%20anti-epileptic%20drugs%20during%20pregnancy:%20a%20systematic%20review%20and%20network%20meta-analysis%20of%20congenital%20malformations%20and%20prenatal%20outcomes&amp;author=AA%20Veroniki&amp;author=E%20Cogo&amp;author=P%20Rios&amp;author=SE%20Straus&amp;author=Y%20Finkelstein&amp;volume=15&amp;issue=1&amp;publication_year=2017&amp;pmid=28472982&amp;doi=10.1186/s12916-017-0845-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref022">
<span class="label">22.</span><cite>Eriksson Y, Boström M, Sandelius Å, Blennow K, Zetterberg H, Kuhn G, et al. The anti-asthmatic drug, montelukast, modifies the neurogenic potential in the young healthy and irradiated brain. Cell Death Dis. 2018;9(7). doi: 10.1038/s41419-018-0783-7</cite> [<a href="https://doi.org/10.1038/s41419-018-0783-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6039496/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29991719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Death%20Dis&amp;title=The%20anti-asthmatic%20drug,%20montelukast,%20modifies%20the%20neurogenic%20potential%20in%20the%20young%20healthy%20and%20irradiated%20brain&amp;author=Y%20Eriksson&amp;author=M%20Bostr%C3%B6m&amp;author=%C3%85%20Sandelius&amp;author=K%20Blennow&amp;author=H%20Zetterberg&amp;volume=9&amp;issue=7&amp;publication_year=2018&amp;pmid=29991719&amp;doi=10.1038/s41419-018-0783-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref023">
<span class="label">23.</span><cite>Zhao R, Shi W-Z, Zhang Y-M, Fang S-H, Wei E-Q. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats. Journal of Pharmacy and Pharmacology. 2011;63(4):550–7. doi: 10.1111/j.2042-7158.2010.01238.x
</cite> [<a href="https://doi.org/10.1111/j.2042-7158.2010.01238.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21401607/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacy%20and%20Pharmacology&amp;title=Montelukast,%20a%20cysteinyl%20leukotriene%20receptor-1%20antagonist,%20attenuates%20chronic%20brain%20injury%20after%20focal%20cerebral%20ischaemia%20in%20mice%20and%20rats&amp;author=R%20Zhao&amp;author=W-Z%20Shi&amp;author=Y-M%20Zhang&amp;author=S-H%20Fang&amp;author=E-Q%20Wei&amp;volume=63&amp;issue=4&amp;publication_year=2011&amp;pages=550-7&amp;pmid=21401607&amp;doi=10.1111/j.2042-7158.2010.01238.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref024">
<span class="label">24.</span><cite>Marschallinger J, Schäffner I, Klein B, Gelfert R, Rivera FJ, Illes S, et al. Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug. Nat Commun. 2015;6(1). doi: 10.1038/ncomms9466</cite> [<a href="https://doi.org/10.1038/ncomms9466" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4639806/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26506265/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Commun&amp;title=Structural%20and%20functional%20rejuvenation%20of%20the%20aged%20brain%20by%20an%20approved%20anti-asthmatic%20drug&amp;author=J%20Marschallinger&amp;author=I%20Sch%C3%A4ffner&amp;author=B%20Klein&amp;author=R%20Gelfert&amp;author=FJ%20Rivera&amp;volume=6&amp;issue=1&amp;publication_year=2015&amp;pmid=26506265&amp;doi=10.1038/ncomms9466&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref025">
<span class="label">25.</span><cite>Sansing-Foster V, Haug N, Mosholder A, Cocoros NM, Bradley M, Ma Y, et al. Risk of Psychiatric Adverse Events Among Montelukast Users. The Journal of Allergy and Clinical Immunology: In Practice. 2021;9(1):385-393.e12. doi: 10.1016/j.jaip.2020.07.052</cite> [<a href="https://doi.org/10.1016/j.jaip.2020.07.052" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32795564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=The%20Journal%20of%20Allergy%20and%20Clinical%20Immunology:%20In%20Practice&amp;title=Risk%20of%20Psychiatric%20Adverse%20Events%20Among%20Montelukast%20Users&amp;author=V%20Sansing-Foster&amp;author=N%20Haug&amp;author=A%20Mosholder&amp;author=NM%20Cocoros&amp;author=M%20Bradley&amp;volume=9&amp;issue=1&amp;publication_year=2021&amp;pmid=32795564&amp;doi=10.1016/j.jaip.2020.07.052&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref026">
<span class="label">26.</span><cite>Paljarvi T, Forton J, Luciano S, Herttua K, Fazel S. Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation. JAMA Netw Open. 2022;5(5):e2213643. doi: 10.1001/jamanetworkopen.2022.13643</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2022.13643" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9131741/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35608857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Netw%20Open&amp;title=Analysis%20of%20Neuropsychiatric%20Diagnoses%20After%20Montelukast%20Initiation&amp;author=T%20Paljarvi&amp;author=J%20Forton&amp;author=S%20Luciano&amp;author=K%20Herttua&amp;author=S%20Fazel&amp;volume=5&amp;issue=5&amp;publication_year=2022&amp;pmid=35608857&amp;doi=10.1001/jamanetworkopen.2022.13643&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref027">
<span class="label">27.</span><cite>Lo CWH, Pathadka S, Qin SX, Fung LWY, Yan VKC, Yiu HHE, et al. Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review. Eur Respir Rev. 2023;32(169):230079. doi: 10.1183/16000617.0079-2023
</cite> [<a href="https://doi.org/10.1183/16000617.0079-2023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10523155/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37758273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Respir%20Rev&amp;title=Neuropsychiatric%20events%20associated%20with%20montelukast%20in%20patients%20with%20asthma:%20a%20systematic%20review&amp;author=CWH%20Lo&amp;author=S%20Pathadka&amp;author=SX%20Qin&amp;author=LWY%20Fung&amp;author=VKC%20Yan&amp;volume=32&amp;issue=169&amp;publication_year=2023&amp;pages=230079&amp;pmid=37758273&amp;doi=10.1183/16000617.0079-2023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref028">
<span class="label">28.</span><cite>Tesfaye BA, Hailu HG, Zewdie KA, Ayza MA, Berhe DF. Montelukast: The New Therapeutic Option for the Treatment of Epilepsy. JEP. 2021;Volume 13:23–31. doi: 10.2147/jep.s277720</cite> [<a href="https://doi.org/10.2147/jep.s277720" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7829127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33505173/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JEP&amp;title=Montelukast:%20The%20New%20Therapeutic%20Option%20for%20the%20Treatment%20of%20Epilepsy&amp;author=BA%20Tesfaye&amp;author=HG%20Hailu&amp;author=KA%20Zewdie&amp;author=MA%20Ayza&amp;author=DF%20Berhe&amp;publication_year=2021&amp;pages=23-31&amp;pmid=33505173&amp;doi=10.2147/jep.s277720&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref029">
<span class="label">29.</span><cite>Torres PHM, Sodero ACR, Jofily P, Silva-Jr FP. Key Topics in Molecular Docking for Drug Design. IJMS. 2019;20(18):4574. doi: 10.3390/ijms20184574
</cite> [<a href="https://doi.org/10.3390/ijms20184574" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6769580/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31540192/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=IJMS&amp;title=Key%20Topics%20in%20Molecular%20Docking%20for%20Drug%20Design&amp;author=PHM%20Torres&amp;author=ACR%20Sodero&amp;author=P%20Jofily&amp;author=FP%20Silva-Jr&amp;volume=20&amp;issue=18&amp;publication_year=2019&amp;pages=4574&amp;pmid=31540192&amp;doi=10.3390/ijms20184574&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref030">
<span class="label">30.</span><cite>Federico LB, Santos CBR dos, Lobato CC, Gomes JS, Rosa JMC, Silva CHTP da. Ligand- and Structure-Based Drug Design of Novel Calcium Channel Blockers. J Comput Theor Nanosci. 2017;14(7):3489–502. doi: 10.1166/jctn.2017.6519</cite> [<a href="https://doi.org/10.1166/jctn.2017.6519" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Comput%20Theor%20Nanosci&amp;title=Ligand-%20and%20Structure-Based%20Drug%20Design%20of%20Novel%20Calcium%20Channel%20Blockers&amp;author=LB%20Federico&amp;author=CBR%20dos%20Santos&amp;author=CC%20Lobato&amp;author=JS%20Gomes&amp;author=JMC%20Rosa&amp;volume=14&amp;issue=7&amp;publication_year=2017&amp;pages=3489-502&amp;doi=10.1166/jctn.2017.6519&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref031">
<span class="label">31.</span><cite>Li Y, Han L, Liu Z, Wang R. Comparative Assessment of Scoring Functions on an Updated Benchmark: 2. Evaluation Methods and General Results. J Chem Inf Model. 2014;54(6):1717–36. doi: 10.1021/ci500081m
</cite> [<a href="https://doi.org/10.1021/ci500081m" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24708446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Chem%20Inf%20Model&amp;title=Comparative%20Assessment%20of%20Scoring%20Functions%20on%20an%20Updated%20Benchmark:%202.%20Evaluation%20Methods%20and%20General%20Results&amp;author=Y%20Li&amp;author=L%20Han&amp;author=Z%20Liu&amp;author=R%20Wang&amp;volume=54&amp;issue=6&amp;publication_year=2014&amp;pages=1717-36&amp;pmid=24708446&amp;doi=10.1021/ci500081m&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref032">
<span class="label">32.</span><cite>Kumar P, Sheokand D, Grewal A, Saini V, Kumar A. Clinical side-effects based drug repositioning for anti-epileptic activity. Journal of Biomolecular Structure and Dynamics. 2023;42(3):1443–54. doi: 10.1080/07391102.2023.2199874
</cite> [<a href="https://doi.org/10.1080/07391102.2023.2199874" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37042987/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biomolecular%20Structure%20and%20Dynamics&amp;title=Clinical%20side-effects%20based%20drug%20repositioning%20for%20anti-epileptic%20activity&amp;author=P%20Kumar&amp;author=D%20Sheokand&amp;author=A%20Grewal&amp;author=V%20Saini&amp;author=A%20Kumar&amp;volume=42&amp;issue=3&amp;publication_year=2023&amp;pages=1443-54&amp;pmid=37042987&amp;doi=10.1080/07391102.2023.2199874&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref033">
<span class="label">33.</span><cite>Lv X, Wang J, Yuan Y, Pan L, Liu Q, Guo J. In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy. Sci Rep. 2024;14(1). doi: 10.1038/s41598-024-67594-6</cite> [<a href="https://doi.org/10.1038/s41598-024-67594-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11254927/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39020064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=In%20Silico%20drug%20repurposing%20pipeline%20using%20deep%20learning%20and%20structure%20based%20approaches%20in%20epilepsy&amp;author=X%20Lv&amp;author=J%20Wang&amp;author=Y%20Yuan&amp;author=L%20Pan&amp;author=Q%20Liu&amp;volume=14&amp;issue=1&amp;publication_year=2024&amp;pmid=39020064&amp;doi=10.1038/s41598-024-67594-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref034">
<span class="label">34.</span><cite>Depuydt A-S, Rihon J, Cheneval O, Vanmeert M, Schroeder CI, Craik DJ, et al. Cyclic Peptides as T-Type Calcium Channel Blockers: Characterization and Molecular Mapping of the Binding Site. ACS Pharmacol Transl Sci. 2021;4(4):1379–89. doi: 10.1021/acsptsci.1c00079
</cite> [<a href="https://doi.org/10.1021/acsptsci.1c00079" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8369677/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34423272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Pharmacol%20Transl%20Sci&amp;title=Cyclic%20Peptides%20as%20T-Type%20Calcium%20Channel%20Blockers:%20Characterization%20and%20Molecular%20Mapping%20of%20the%20Binding%20Site&amp;author=A-S%20Depuydt&amp;author=J%20Rihon&amp;author=O%20Cheneval&amp;author=M%20Vanmeert&amp;author=CI%20Schroeder&amp;volume=4&amp;issue=4&amp;publication_year=2021&amp;pages=1379-89&amp;pmid=34423272&amp;doi=10.1021/acsptsci.1c00079&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref035">
<span class="label">35.</span><cite>Ke Q, Gong X, Liao S, Duan C, Li L. Effects of thermostats/barostats on physical properties of liquids by molecular dynamics simulations. J Molecular Liquids. 2022;365:120116. doi: 10.1016/j.molliq.2022.120116</cite> [<a href="https://doi.org/10.1016/j.molliq.2022.120116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Molecular%20Liquids&amp;title=Effects%20of%20thermostats/barostats%20on%20physical%20properties%20of%20liquids%20by%20molecular%20dynamics%20simulations&amp;author=Q%20Ke&amp;author=X%20Gong&amp;author=S%20Liao&amp;author=C%20Duan&amp;author=L%20Li&amp;volume=365&amp;publication_year=2022&amp;pages=120116&amp;doi=10.1016/j.molliq.2022.120116&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref036">
<span class="label">36.</span><cite>Brodie MJ, Mintzer S, Pack AM, Gidal BE, Vecht CJ, Schmidt D. Enzyme induction with antiepileptic drugs: Cause for concern?. Epilepsia. 2012;54(1):11–27. doi: 10.1111/j.1528-1167.2012.03671.x
</cite> [<a href="https://doi.org/10.1111/j.1528-1167.2012.03671.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23016553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;title=Enzyme%20induction%20with%20antiepileptic%20drugs:%20Cause%20for%20concern?&amp;author=MJ%20Brodie&amp;author=S%20Mintzer&amp;author=AM%20Pack&amp;author=BE%20Gidal&amp;author=CJ%20Vecht&amp;volume=54&amp;issue=1&amp;publication_year=2012&amp;pages=11-27&amp;pmid=23016553&amp;doi=10.1111/j.1528-1167.2012.03671.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref037">
<span class="label">37.</span><cite>Méry PF, Hove‐Madsen L, Mazet JL, Hanf R, Fischmeister R. Binding constants determined from Ca2+ current responses to rapid applications and washouts of nifedipine in frog cardiac myocytes. J Physiol. 1996;494(1):105–20. doi: 10.1113/jphysiol.1996.sp021479
</cite> [<a href="https://doi.org/10.1113/jphysiol.1996.sp021479" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1160618/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8814610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Physiol&amp;title=Binding%20constants%20determined%20from%20Ca2+%20current%20responses%20to%20rapid%20applications%20and%20washouts%20of%20nifedipine%20in%20frog%20cardiac%20myocytes&amp;author=PF%20M%C3%A9ry&amp;author=L%20Hove%E2%80%90Madsen&amp;author=JL%20Mazet&amp;author=R%20Hanf&amp;author=R%20Fischmeister&amp;volume=494&amp;issue=1&amp;publication_year=1996&amp;pages=105-20&amp;pmid=8814610&amp;doi=10.1113/jphysiol.1996.sp021479&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref038">
<span class="label">38.</span><cite>Mirlohi S, Bladen C, Santiago MJ, Arnold JC, McGregor I, Connor M. Inhibition of human recombinant T‐type calcium channels by phytocannabinoids in vitro. British J Pharmacology. 2022;179(15):4031–43. doi: 10.1111/bph.15842</cite> [<a href="https://doi.org/10.1111/bph.15842" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35342937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20J%20Pharmacology&amp;title=Inhibition%20of%20human%20recombinant%20T%E2%80%90type%20calcium%20channels%20by%20phytocannabinoids%20in%20vitro&amp;author=S%20Mirlohi&amp;author=C%20Bladen&amp;author=MJ%20Santiago&amp;author=JC%20Arnold&amp;author=I%20McGregor&amp;volume=179&amp;issue=15&amp;publication_year=2022&amp;pages=4031-43&amp;pmid=35342937&amp;doi=10.1111/bph.15842&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref039">
<span class="label">39.</span><cite>Zhao Y, Huang G, Wu Q, Wu K, Li R, Lei J, et al. Cryo-EM structures of apo and antagonist-bound human Cav3.1. Nature. 2019;576(7787):492–7. doi: 10.1038/s41586-019-1801-3
</cite> [<a href="https://doi.org/10.1038/s41586-019-1801-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31766050/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Cryo-EM%20structures%20of%20apo%20and%20antagonist-bound%20human%20Cav3.1&amp;author=Y%20Zhao&amp;author=G%20Huang&amp;author=Q%20Wu&amp;author=K%20Wu&amp;author=R%20Li&amp;volume=576&amp;issue=7787&amp;publication_year=2019&amp;pages=492-7&amp;pmid=31766050&amp;doi=10.1038/s41586-019-1801-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref040">
<span class="label">40.</span><cite>Casillas-Espinosa PM, Hicks A, Jeffreys A, Snutch TP, O’Brien TJ, Powell KL. Z944, a Novel Selective T-Type Calcium Channel Antagonist Delays the Progression of Seizures in the Amygdala Kindling Model. PLoS ONE. 2015;10(8):e0130012. doi: 10.1371/journal.pone.0130012</cite> [<a href="https://doi.org/10.1371/journal.pone.0130012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4537250/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26274319/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Z944,%20a%20Novel%20Selective%20T-Type%20Calcium%20Channel%20Antagonist%20Delays%20the%20Progression%20of%20Seizures%20in%20the%20Amygdala%20Kindling%20Model&amp;author=PM%20Casillas-Espinosa&amp;author=A%20Hicks&amp;author=A%20Jeffreys&amp;author=TP%20Snutch&amp;author=TJ%20O%E2%80%99Brien&amp;volume=10&amp;issue=8&amp;publication_year=2015&amp;pmid=26274319&amp;doi=10.1371/journal.pone.0130012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref041">
<span class="label">41.</span><cite>Beltrán JF, Belén LH, Lee-Estevez M, Figueroa E, Dumorné K, Farias JG. The voltage-gated T-type Ca2+ channel is key to the sperm motility of Atlantic salmon (Salmo salar). Fish Physiol Biochem. 2020;46(5):1825–31. doi: 10.1007/s10695-020-00829-1
</cite> [<a href="https://doi.org/10.1007/s10695-020-00829-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32506186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Fish%20Physiol%20Biochem&amp;title=The%20voltage-gated%20T-type%20Ca2+%20channel%20is%20key%20to%20the%20sperm%20motility%20of%20Atlantic%20salmon%20(Salmo%20salar)&amp;author=JF%20Beltr%C3%A1n&amp;author=LH%20Bel%C3%A9n&amp;author=M%20Lee-Estevez&amp;author=E%20Figueroa&amp;author=K%20Dumorn%C3%A9&amp;volume=46&amp;issue=5&amp;publication_year=2020&amp;pages=1825-31&amp;pmid=32506186&amp;doi=10.1007/s10695-020-00829-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref042">
<span class="label">42.</span><cite>Li J, Fu A, Zhang L. An Overview of Scoring Functions Used for Protein–Ligand Interactions in Molecular Docking. Interdiscip Sci Comput Life Sci. 2019;11(2):320–8. doi: 10.1007/s12539-019-00327-w</cite> [<a href="https://doi.org/10.1007/s12539-019-00327-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30877639/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Interdiscip%20Sci%20Comput%20Life%20Sci&amp;title=An%20Overview%20of%20Scoring%20Functions%20Used%20for%20Protein%E2%80%93Ligand%20Interactions%20in%20Molecular%20Docking&amp;author=J%20Li&amp;author=A%20Fu&amp;author=L%20Zhang&amp;volume=11&amp;issue=2&amp;publication_year=2019&amp;pages=320-8&amp;pmid=30877639&amp;doi=10.1007/s12539-019-00327-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref043">
<span class="label">43.</span><cite>Jones G, Willett P, Glen RC, Leach AR, Taylor R. Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen. Journal of Molecular Biology. 1997;267(3):727–48. doi: 10.1006/jmbi.1996.0897
</cite> [<a href="https://doi.org/10.1006/jmbi.1996.0897" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9126849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Molecular%20Biology&amp;title=Development%20and%20validation%20of%20a%20genetic%20algorithm%20for%20flexible%20docking%201%201Edited%20by%20F.%20E.%20Cohen&amp;author=G%20Jones&amp;author=P%20Willett&amp;author=RC%20Glen&amp;author=AR%20Leach&amp;author=R%20Taylor&amp;volume=267&amp;issue=3&amp;publication_year=1997&amp;pages=727-48&amp;pmid=9126849&amp;doi=10.1006/jmbi.1996.0897&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref044">
<span class="label">44.</span><cite>Hartshorn MJ, Verdonk ML, Chessari G, Brewerton SC, Mooij WTM, Mortenson PN, et al. Diverse, High-Quality Test Set for the Validation of Protein−Ligand Docking Performance. J Med Chem. 2007;50(4):726–41. doi: 10.1021/jm061277y
</cite> [<a href="https://doi.org/10.1021/jm061277y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17300160/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Chem&amp;title=Diverse,%20High-Quality%20Test%20Set%20for%20the%20Validation%20of%20Protein%E2%88%92Ligand%20Docking%20Performance&amp;author=MJ%20Hartshorn&amp;author=ML%20Verdonk&amp;author=G%20Chessari&amp;author=SC%20Brewerton&amp;author=WTM%20Mooij&amp;volume=50&amp;issue=4&amp;publication_year=2007&amp;pages=726-41&amp;pmid=17300160&amp;doi=10.1021/jm061277y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref045">
<span class="label">45.</span><cite>Korb O, Stützle T, Exner TE. Empirical Scoring Functions for Advanced Protein−Ligand Docking with PLANTS. J Chem Inf Model. 2009;49(1):84–96. doi: 10.1021/ci800298z
</cite> [<a href="https://doi.org/10.1021/ci800298z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19125657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Chem%20Inf%20Model&amp;title=Empirical%20Scoring%20Functions%20for%20Advanced%20Protein%E2%88%92Ligand%20Docking%20with%20PLANTS&amp;author=O%20Korb&amp;author=T%20St%C3%BCtzle&amp;author=TE%20Exner&amp;volume=49&amp;issue=1&amp;publication_year=2009&amp;pages=84-96&amp;pmid=19125657&amp;doi=10.1021/ci800298z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref046">
<span class="label">46.</span><cite>de Oliveira TA, Medaglia LR, Maia EHB, Assis LC, de Carvalho PB, da Silva AM, et al. Evaluation of Docking Machine Learning and Molecular Dynamics Methodologies for DNA-Ligand Systems. Pharmaceuticals. 2022;15(2):132. doi: 10.3390/ph15020132
</cite> [<a href="https://doi.org/10.3390/ph15020132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8874395/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35215245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals&amp;title=Evaluation%20of%20Docking%20Machine%20Learning%20and%20Molecular%20Dynamics%20Methodologies%20for%20DNA-Ligand%20Systems&amp;author=TA%20de%20Oliveira&amp;author=LR%20Medaglia&amp;author=EHB%20Maia&amp;author=LC%20Assis&amp;author=PB%20de%20Carvalho&amp;volume=15&amp;issue=2&amp;publication_year=2022&amp;pages=132&amp;pmid=35215245&amp;doi=10.3390/ph15020132&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref047">
<span class="label">47.</span><cite>Mascarenhas AMS, de Almeida RBM, de Araujo Neto MF, Mendes GO, da Cruz JN, dos Santos CBR, et al. Pharmacophore-based virtual screening and molecular docking to identify promising dual inhibitors of human acetylcholinesterase and butyrylcholinesterase. J Biomolecular Structure and Dynamics. 2020;39(16):6021–30. doi: 10.1080/07391102.2020.1796791</cite> [<a href="https://doi.org/10.1080/07391102.2020.1796791" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32705955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Biomolecular%20Structure%20and%20Dynamics&amp;title=Pharmacophore-based%20virtual%20screening%20and%20molecular%20docking%20to%20identify%20promising%20dual%20inhibitors%20of%20human%20acetylcholinesterase%20and%20butyrylcholinesterase&amp;author=AMS%20Mascarenhas&amp;author=RBM%20de%20Almeida&amp;author=MF%20de%20Araujo%20Neto&amp;author=GO%20Mendes&amp;author=JN%20da%20Cruz&amp;volume=39&amp;issue=16&amp;publication_year=2020&amp;pages=6021-30&amp;pmid=32705955&amp;doi=10.1080/07391102.2020.1796791&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref048">
<span class="label">48.</span><cite>Huang K, Luo S, Cong Y, Zhong S, Zhang JZH, Duan L. An accurate free energy estimator: based on MM/PBSA combined with interaction entropy for protein–ligand binding affinity. Nanoscale. 2020;12(19):10737–50. doi: 10.1039/c9nr10638c
</cite> [<a href="https://doi.org/10.1039/c9nr10638c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32388542/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nanoscale&amp;title=An%20accurate%20free%20energy%20estimator:%20based%20on%20MM/PBSA%20combined%20with%20interaction%20entropy%20for%20protein%E2%80%93ligand%20binding%20affinity&amp;author=K%20Huang&amp;author=S%20Luo&amp;author=Y%20Cong&amp;author=S%20Zhong&amp;author=JZH%20Zhang&amp;volume=12&amp;issue=19&amp;publication_year=2020&amp;pages=10737-50&amp;pmid=32388542&amp;doi=10.1039/c9nr10638c&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref049">
<span class="label">49.</span><cite>Guterres H, Im W. Improving Protein-Ligand Docking Results with High-Throughput Molecular Dynamics Simulations. J Chem Inf Model. 2020;60(4):2189–98. doi: 10.1021/acs.jcim.0c00057
</cite> [<a href="https://doi.org/10.1021/acs.jcim.0c00057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7534544/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32227880/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Chem%20Inf%20Model&amp;title=Improving%20Protein-Ligand%20Docking%20Results%20with%20High-Throughput%20Molecular%20Dynamics%20Simulations&amp;author=H%20Guterres&amp;author=W%20Im&amp;volume=60&amp;issue=4&amp;publication_year=2020&amp;pages=2189-98&amp;pmid=32227880&amp;doi=10.1021/acs.jcim.0c00057&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref050">
<span class="label">50.</span><cite>Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJC. GROMACS: Fast, flexible, and free. J Comput Chem. 2005;26(16):1701–18. doi: 10.1002/jcc.20291
</cite> [<a href="https://doi.org/10.1002/jcc.20291" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16211538/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Comput%20Chem&amp;title=GROMACS:%20Fast,%20flexible,%20and%20free&amp;author=D%20Van%20Der%20Spoel&amp;author=E%20Lindahl&amp;author=B%20Hess&amp;author=G%20Groenhof&amp;author=AE%20Mark&amp;volume=26&amp;issue=16&amp;publication_year=2005&amp;pages=1701-18&amp;pmid=16211538&amp;doi=10.1002/jcc.20291&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref051">
<span class="label">51.</span><cite>Eisenhaber F, Lijnzaad P, Argos P, Sander C, Scharf M. The double cubic lattice method: Efficient approaches to numerical integration of surface area and volume and to dot surface contouring of molecular assemblies. J Comput Chem. 1995;16(3):273–84. doi: 10.1002/jcc.540160303</cite> [<a href="https://doi.org/10.1002/jcc.540160303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Comput%20Chem&amp;title=The%20double%20cubic%20lattice%20method:%20Efficient%20approaches%20to%20numerical%20integration%20of%20surface%20area%20and%20volume%20and%20to%20dot%20surface%20contouring%20of%20molecular%20assemblies&amp;author=F%20Eisenhaber&amp;author=P%20Lijnzaad&amp;author=P%20Argos&amp;author=C%20Sander&amp;author=M%20Scharf&amp;volume=16&amp;issue=3&amp;publication_year=1995&amp;pages=273-84&amp;doi=10.1002/jcc.540160303&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref052">
<span class="label">52.</span><cite>Vanommeslaeghe K, Hatcher E, Acharya C, Kundu S, Zhong S, Shim J, et al. CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fields. J Comput Chem. 2009;31(4):671–90. doi: 10.1002/jcc.21367</cite> [<a href="https://doi.org/10.1002/jcc.21367" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2888302/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19575467/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Comput%20Chem&amp;title=CHARMM%20general%20force%20field:%20A%20force%20field%20for%20drug%E2%80%90like%20molecules%20compatible%20with%20the%20CHARMM%20all%E2%80%90atom%20additive%20biological%20force%20fields&amp;author=K%20Vanommeslaeghe&amp;author=E%20Hatcher&amp;author=C%20Acharya&amp;author=S%20Kundu&amp;author=S%20Zhong&amp;volume=31&amp;issue=4&amp;publication_year=2009&amp;pages=671-90&amp;pmid=19575467&amp;doi=10.1002/jcc.21367&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref053">
<span class="label">53.</span><cite>Vanommeslaeghe K, Raman EP, MacKerell AD Jr. Automation of the CHARMM General Force Field (CGenFF) II: Assignment of Bonded Parameters and Partial Atomic Charges. J Chem Inf Model. 2012;52(12):3155–68. doi: 10.1021/ci3003649
</cite> [<a href="https://doi.org/10.1021/ci3003649" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3528813/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23145473/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Chem%20Inf%20Model&amp;title=Automation%20of%20the%20CHARMM%20General%20Force%20Field%20(CGenFF)%20II:%20Assignment%20of%20Bonded%20Parameters%20and%20Partial%20Atomic%20Charges&amp;author=K%20Vanommeslaeghe&amp;author=EP%20Raman&amp;author=AD%20MacKerell&amp;volume=52&amp;issue=12&amp;publication_year=2012&amp;pages=3155-68&amp;pmid=23145473&amp;doi=10.1021/ci3003649&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref054">
<span class="label">54.</span><cite>Vanommeslaeghe K, MacKerell AD Jr. Automation of the CHARMM General Force Field (CGenFF) I: Bond Perception and Atom Typing. J Chem Inf Model. 2012;52(12):3144–54. doi: 10.1021/ci300363c
</cite> [<a href="https://doi.org/10.1021/ci300363c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3528824/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23146088/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Chem%20Inf%20Model&amp;title=Automation%20of%20the%20CHARMM%20General%20Force%20Field%20(CGenFF)%20I:%20Bond%20Perception%20and%20Atom%20Typing&amp;author=K%20Vanommeslaeghe&amp;author=AD%20MacKerell&amp;volume=52&amp;issue=12&amp;publication_year=2012&amp;pages=3144-54&amp;pmid=23146088&amp;doi=10.1021/ci300363c&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref055">
<span class="label">55.</span><cite>Mark P, Nilsson L. Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K. J Phys Chem A. 2001;105(43):9954–60. doi: 10.1021/jp003020w</cite> [<a href="https://doi.org/10.1021/jp003020w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Phys%20Chem%20A&amp;title=Structure%20and%20Dynamics%20of%20the%20TIP3P,%20SPC,%20and%20SPC/E%20Water%20Models%20at%20298%20K&amp;author=P%20Mark&amp;author=L%20Nilsson&amp;volume=105&amp;issue=43&amp;publication_year=2001&amp;pages=9954-60&amp;doi=10.1021/jp003020w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref056">
<span class="label">56.</span><cite>Ilnytskyi JM, Wilson MR. A domain decomposition molecular dynamics program for the simulation of flexible molecules of spherically-symmetrical and nonspherical sites. II. Extension to NVT and NPT ensembles. Comput Phys Commun. 2002;148: 43–58. doi: 10.1016/S0010-4655(02)00467-8</cite> [<a href="https://doi.org/10.1016/S0010-4655(02)00467-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Comput%20Phys%20Commun&amp;title=A%20domain%20decomposition%20molecular%20dynamics%20program%20for%20the%20simulation%20of%20flexible%20molecules%20of%20spherically-symmetrical%20and%20nonspherical%20sites.%20II.%20Extension%20to%20NVT%20and%20NPT%20ensembles&amp;author=JM%20Ilnytskyi&amp;author=MR%20Wilson&amp;volume=148&amp;publication_year=2002&amp;pages=43-58&amp;doi=10.1016/S0010-4655(02)00467-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref057">
<span class="label">57.</span><cite>Abraham MJ, Gready JE. Optimization of parameters for molecular dynamics simulation using smooth particle‐mesh Ewald in GROMACS 4.5. J Comput Chem. 2011;32(9):2031–40. doi: 10.1002/jcc.21773
</cite> [<a href="https://doi.org/10.1002/jcc.21773" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21469158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Comput%20Chem&amp;title=Optimization%20of%20parameters%20for%20molecular%20dynamics%20simulation%20using%20smooth%20particle%E2%80%90mesh%20Ewald%20in%20GROMACS%204.5&amp;author=MJ%20Abraham&amp;author=JE%20Gready&amp;volume=32&amp;issue=9&amp;publication_year=2011&amp;pages=2031-40&amp;pmid=21469158&amp;doi=10.1002/jcc.21773&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref058">
<span class="label">58.</span><cite>Lemkul JA. Introductory Tutorials for Simulating Protein Dynamics with GROMACS. J Phys Chem B. 2024;128(39):9418–35. doi: 10.1021/acs.jpcb.4c04901
</cite> [<a href="https://doi.org/10.1021/acs.jpcb.4c04901" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11457149/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39305267/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Phys%20Chem%20B&amp;title=Introductory%20Tutorials%20for%20Simulating%20Protein%20Dynamics%20with%20GROMACS&amp;author=JA%20Lemkul&amp;volume=128&amp;issue=39&amp;publication_year=2024&amp;pages=9418-35&amp;pmid=39305267&amp;doi=10.1021/acs.jpcb.4c04901&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref059">
<span class="label">59.</span><cite>Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery. 2015;10(5):449–61. doi: 10.1517/17460441.2015.1032936
</cite> [<a href="https://doi.org/10.1517/17460441.2015.1032936" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4487606/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25835573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opinion%20on%20Drug%20Discovery&amp;title=The%20MM/PBSA%20and%20MM/GBSA%20methods%20to%20estimate%20ligand-binding%20affinities&amp;author=S%20Genheden&amp;author=U%20Ryde&amp;volume=10&amp;issue=5&amp;publication_year=2015&amp;pages=449-61&amp;pmid=25835573&amp;doi=10.1517/17460441.2015.1032936&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref060">
<span class="label">60.</span><cite>Sun H, Li Y, Tian S, Xu L, Hou T. Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Phys Chem Chem Phys. 2014;16(31):16719–29. doi: 10.1039/c4cp01388c
</cite> [<a href="https://doi.org/10.1039/c4cp01388c" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24999761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Phys%20Chem%20Chem%20Phys&amp;title=Assessing%20the%20performance%20of%20MM/PBSA%20and%20MM/GBSA%20methods.%204.%20Accuracies%20of%20MM/PBSA%20and%20MM/GBSA%20methodologies%20evaluated%20by%20various%20simulation%20protocols%20using%20PDBbind%20data%20set&amp;author=H%20Sun&amp;author=Y%20Li&amp;author=S%20Tian&amp;author=L%20Xu&amp;author=T%20Hou&amp;volume=16&amp;issue=31&amp;publication_year=2014&amp;pages=16719-29&amp;pmid=24999761&amp;doi=10.1039/c4cp01388c&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref061">
<span class="label">61.</span><cite>Valdés-Tresanco MS, Valdés-Tresanco ME, Valiente PA, Moreno E. gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS. J Chem Theory Comput. 2021;17(10):6281–91. doi: 10.1021/acs.jctc.1c00645
</cite> [<a href="https://doi.org/10.1021/acs.jctc.1c00645" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34586825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Chem%20Theory%20Comput&amp;title=gmx_MMPBSA:%20A%20New%20Tool%20to%20Perform%20End-State%20Free%20Energy%20Calculations%20with%20GROMACS&amp;author=MS%20Vald%C3%A9s-Tresanco&amp;author=ME%20Vald%C3%A9s-Tresanco&amp;author=PA%20Valiente&amp;author=E%20Moreno&amp;volume=17&amp;issue=10&amp;publication_year=2021&amp;pages=6281-91&amp;pmid=34586825&amp;doi=10.1021/acs.jctc.1c00645&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref062">
<span class="label">62.</span><cite>Filippov SV. Blender software platform as an environment for modeling objects and processes of science disciplines. Prepr Keldysh Inst Appl Math. 2018;:230–42.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Prepr%20Keldysh%20Inst%20Appl%20Math&amp;title=Blender%20software%20platform%20as%20an%20environment%20for%20modeling%20objects%20and%20processes%20of%20science%20disciplines&amp;author=SV%20Filippov&amp;publication_year=2018&amp;pages=230-42&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref063">
<span class="label">63.</span><cite>Kerr RA, Bartol TM, Kaminsky B, Dittrich M, Chang J-CJ, Baden SB, et al. Fast Monte Carlo Simulation Methods for Biological Reaction-Diffusion Systems in Solution and on Surfaces. SIAM J Sci Comput. 2008;30(6):3126–49. doi: 10.1137/070692017
</cite> [<a href="https://doi.org/10.1137/070692017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2819163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20151023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=SIAM%20J%20Sci%20Comput&amp;title=Fast%20Monte%20Carlo%20Simulation%20Methods%20for%20Biological%20Reaction-Diffusion%20Systems%20in%20Solution%20and%20on%20Surfaces&amp;author=RA%20Kerr&amp;author=TM%20Bartol&amp;author=B%20Kaminsky&amp;author=M%20Dittrich&amp;author=J-CJ%20Chang&amp;volume=30&amp;issue=6&amp;publication_year=2008&amp;pages=3126-49&amp;pmid=20151023&amp;doi=10.1137/070692017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref064">
<span class="label">64.</span><cite>Stiles JR, Van Helden D, Bartol TM Jr, Salpeter EE, Salpeter MM. Miniature endplate current rise times less than 100 microseconds from improved dual recordings can be modeled with passive acetylcholine diffusion from a synaptic vesicle. Proc Natl Acad Sci USA. 1996;93(12):5747–52. doi: 10.1073/pnas.93.12.5747
</cite> [<a href="https://doi.org/10.1073/pnas.93.12.5747" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC39132/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8650164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20USA&amp;title=Miniature%20endplate%20current%20rise%20times%20less%20than%20100%20microseconds%20from%20improved%20dual%20recordings%20can%20be%20modeled%20with%20passive%20acetylcholine%20diffusion%20from%20a%20synaptic%20vesicle&amp;author=JR%20Stiles&amp;author=D%20Van%20Helden&amp;author=TM%20Bartol&amp;author=EE%20Salpeter&amp;author=MM%20Salpeter&amp;volume=93&amp;issue=12&amp;publication_year=1996&amp;pages=5747-52&amp;pmid=8650164&amp;doi=10.1073/pnas.93.12.5747&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref065">
<span class="label">65.</span><cite>Stiles JR, Bartol TM. Monte Carlo methods for simulating realistic synaptic microphysiology using MCell. Comput Neurosci Realistic Model Exp. 2001. p. 87–127.</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Comput%20Neurosci%20Realistic%20Model%20Exp&amp;author=JR%20Stiles&amp;author=TM%20Bartol&amp;publication_year=2001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref066">
<span class="label">66.</span><cite>Antunes G, Simoes de Souza FM. 3D Modeling of Dendritic Spines with Synaptic Plasticity. JoVE. 2020;(159). doi: 10.3791/60896</cite> [<a href="https://doi.org/10.3791/60896" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32478719/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JoVE&amp;title=3D%20Modeling%20of%20Dendritic%20Spines%20with%20Synaptic%20Plasticity&amp;author=G%20Antunes&amp;author=FM%20Simoes%20de%20Souza&amp;issue=159&amp;publication_year=2020&amp;pmid=32478719&amp;doi=10.3791/60896&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref067">
<span class="label">67.</span><cite>Gupta S, Czech J, Kuczewski R, Bartol TM, Sejnowski TJ, Lee RE. Spatial stochastic modeling with MCell and CellBlender. ArXiv Preprint. 2018.</cite>
</li>
<li id="pone.0327386.ref068">
<span class="label">68.</span><cite>Pharris MC, Patel NM, VanDyk TG, Bartol TM, Sejnowski TJ, Kennedy MB, et al. A multi-state model of the CaMKII dodecamer suggests a role for calmodulin in maintenance of autophosphorylation. PLoS Comput Biol. 2019;15(12):e1006941. doi: 10.1371/journal.pcbi.1006941</cite> [<a href="https://doi.org/10.1371/journal.pcbi.1006941" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6957207/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31869343/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Comput%20Biol&amp;title=A%20multi-state%20model%20of%20the%20CaMKII%20dodecamer%20suggests%20a%20role%20for%20calmodulin%20in%20maintenance%20of%20autophosphorylation&amp;author=MC%20Pharris&amp;author=NM%20Patel&amp;author=TG%20VanDyk&amp;author=TM%20Bartol&amp;author=TJ%20Sejnowski&amp;volume=15&amp;issue=12&amp;publication_year=2019&amp;pmid=31869343&amp;doi=10.1371/journal.pcbi.1006941&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref069">
<span class="label">69.</span><cite>Influence Blocking by gadolinium in calcium diffusion on synapse model: a monte carlo simulation study. jape. 2020;10(3). doi: 10.31661/jbpe.v0i0.1155</cite> [<a href="https://doi.org/10.31661/jbpe.v0i0.1155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7321394/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32637369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=jape&amp;title=Influence%20Blocking%20by%20gadolinium%20in%20calcium%20diffusion%20on%20synapse%20model:%20a%20monte%20carlo%20simulation%20study&amp;volume=10&amp;issue=3&amp;publication_year=2020&amp;pmid=32637369&amp;doi=10.31661/jbpe.v0i0.1155&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0327386.ref070">
<span class="label">70.</span><cite>Brini M, Calì T, Ottolini D, Carafoli E. Neuronal calcium signaling: function and dysfunction. Cell Mol Life Sci. 2014;71(15):2787–814. doi: 10.1007/s00018-013-1550-7
</cite> [<a href="https://doi.org/10.1007/s00018-013-1550-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11113927/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24442513/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Mol%20Life%20Sci&amp;title=Neuronal%20calcium%20signaling:%20function%20and%20dysfunction&amp;author=M%20Brini&amp;author=T%20Cal%C3%AC&amp;author=D%20Ottolini&amp;author=E%20Carafoli&amp;volume=71&amp;issue=15&amp;publication_year=2014&amp;pages=2787-814&amp;pmid=24442513&amp;doi=10.1007/s00018-013-1550-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All relevant data are within the paper and available on Zenodo at <a href="https://doi.org/10.5281/zenodo.13831314" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.5281/zenodo.13831314</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS One are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0327386"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0327386.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.3 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12334052/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12334052/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12334052%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12334052/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12334052/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12334052/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40779495/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12334052/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40779495/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12334052/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12334052/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="JaJfU0rnCXOFjrTmxvbKHm9G0vgP7xWTm12ZlQkTeksiGTfxgSYpjJ9iPgzbswEV">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-d9849939.js"></script>
    
    

    </body>
</html>
